Maciej Banach

Q: What Schools Are Affiliated With Maciej Banach

Maciej Banach is affiliated with the following schools: University of Alabama at Birmingham, University of Liverpool, Medical University of Łódź, McGill University, Victor Babeș University of Medicine and Pharmacy, Timișoara, University of Zielona Góra

Maciej Banach's AcademicInfluence.com Rankings

Maciej Banach

Medical

#1011

World Rank

#1299

Historical Rank

Cardiology

#53

World Rank

#54

Historical Rank

medical Degrees

Maciej Banach

Philosophy

#3527

World Rank

#5682

Historical Rank

Logic

#1211

World Rank

#1902

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Maciej Banach Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Maciej Banach's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (5789)
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2020) (4169)
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults (2017) (3677)
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (3308)
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 (2020) (2362)
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (2239)
Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (2141)
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2020) (2016)
Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2020) (1788)
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (1515)
Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2019) (1485)
Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2018) (1481)
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2021) (822)
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants (2021) (585)
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 (2018) (561)
Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (538)
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019 (2020) (522)
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2020) (492)
GLOBAL, REGIONAL, AND COUNTRY-SPECIFIC LIFETIME RISK OF STROKE, 1990–2016 (2018) (453)
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 (2021) (331)
Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper (2020) (311)
Complications of Diabetes 2017 (2018) (305)
Rising rural body-mass index is the main driver of the global obesity epidemic in adults (2019) (300)
Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel (2015) (299)
Atrial Fibrillation After Isolated Coronary Surgery Affects Late Survival (2008) (296)
Five insights from the Global Burden of Disease Study 2019 (2020) (291)
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel (2017) (289)
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2020) (279)
Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (2019) (273)
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 (2021) (259)
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study. (2020) (256)
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study. (2020) (256)
Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction. (2017) (239)
Incidence and predictors of delirium after cardiac surgery: Results from The IPDACS Study. (2010) (222)
Potential effects of curcumin in the treatment of COVID‐19 infection (2020) (213)
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance (2019) (211)
Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study. (2018) (208)
Statins and the COVID-19 main protease: in silico evidence on direct interaction (2020) (203)
Complications of Diabetes 2016 (2016) (198)
Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease? (2012) (195)
The Role of Nutraceuticals in Statin Intolerant Patients. (2018) (191)
May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension (2019) (182)
The role of Toll-like receptors in renal diseases (2010) (175)
Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies (2015) (175)
Effects of Quercetin on Blood Pressure: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials (2016) (170)
Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. (2015) (170)
Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel (2015) (167)
Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials (2015) (166)
Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients. (2015) (163)
Optimizing Cholesterol Treatment in Patients With Muscle Complaints. (2017) (161)
Leptin, cardiovascular diseases and type 2 diabetes mellitus (2018) (158)
Phytol: A review of biomedical activities. (2018) (157)
Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel# (2017) (151)
Lipid-modifying effects of nutraceuticals: An evidence-based approach. (2016) (149)
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). (2018) (147)
Effects of curcumin on HDL functionality (2017) (146)
Familial hypercholesterolaemia: A global call to arms. (2015) (144)
Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017 (2020) (142)
Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants (2020) (138)
Telemedicine Across the Globe-Position Paper From the COVID-19 Pandemic Health System Resilience PROGRAM (REPROGRAM) International Consortium (Part 1) (2020) (135)
Statin therapy and plasma coenzyme Q10 concentrations--A systematic review and meta-analysis of placebo-controlled trials. (2015) (135)
Risk factors of atrial fibrillation following coronary artery bypass grafting: a preliminary report. (2006) (134)
Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases (2016) (133)
The burden of unintentional drowning: global, regional and national estimates of mortality from the Global Burden of Disease 2017 Study (2020) (132)
Management of Statin Intolerance in 2018: Still More Questions Than Answers (2018) (131)
Statin non-adherence and residual cardiovascular risk: There is need for substantial improvement. (2016) (131)
Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms. (2016) (130)
Monocyte‐to‐HDL‐cholesterol ratio as a prognostic marker in cardiovascular diseases (2018) (130)
Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016–40 (2018) (130)
Bedside Tool for Predicting the Risk of Postoperative Atrial Fibrillation After Cardiac Surgery: The POAF Score (2014) (128)
The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis. (2017) (125)
Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials. (2015) (125)
A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations (2015) (125)
The impact of statin therapy on plasma levels of von Willebrand factor antigen (2015) (124)
Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors--Results from a systematic review and meta-analysis of randomized controlled trials. (2015) (121)
Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995–2015 (2018) (113)
Association between statin use and plasma D-dimer levels (2015) (112)
Preoperative predictors of delirium after cardiac surgery: a preliminary study. (2006) (110)
Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019 (2021) (108)
Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: a systematic review and meta-analysis of randomized controlled trials (2015) (106)
Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways (2020) (105)
The risk of atherosclerosis in patients with chronic kidney disease (2013) (101)
Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score". (2018) (100)
Should we have any doubts about hypertension therapy in elderly patients?: ACCF/AHA 2011 expert consensus document on hypertension in the elderly. (2011) (100)
The role of fibrate treatment in dyslipidemia: an overview. (2013) (100)
The mechanisms of atrial fibrillation in hyperthyroidism (2009) (99)
A systematic review and meta-analysis of the impact of Spirulina supplementation on plasma lipid concentrations. (2016) (98)
Lipids, blood pressure and kidney update 2015 (2015) (95)
Cholesterol in Relation to COVID-19: Should We Care about It? (2020) (95)
Natural approaches in metabolic syndrome management (2017) (94)
Blood Pressure J-Curve: Current Concepts (2012) (94)
Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants. (2013) (94)
Telemedicine as the New Outpatient Clinic Gone Digital: Position Paper From the Pandemic Health System REsilience PROGRAM (REPROGRAM) International Consortium (Part 2) (2020) (93)
Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study. (2015) (91)
Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study (2020) (91)
Lower carbohydrate diets and all-cause and cause-specific mortality: a population-based cohort study and pooling of prospective studies. (2018) (91)
Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia (2020) (90)
Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: a prospective pilot study. (2015) (88)
Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure. (2011) (88)
Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance. (2017) (87)
Takotsubo cardiomyopathy--the current state of knowledge. (2010) (87)
Effects of a 9-Week Hybrid Comprehensive Telerehabilitation Program on Long-term Outcomes in Patients With Heart Failure: The Telerehabilitation in Heart Failure Patients (TELEREH-HF) Randomized Clinical Trial. (2019) (86)
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration. (2016) (85)
Global, regional, and national burden of bone fractures in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 (2021) (84)
The association of telomere length and serum 25-hydroxyvitamin D levels in US adults: the National Health and Nutrition Examination Survey (2016) (84)
Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy. (2007) (84)
Obesity indices and inflammatory markers in obese non-diabetic normo- and hypertensive patients: a comparative pilot study (2014) (83)
Regulation of PCSK9 by nutraceuticals (2017) (83)
Time for new indications for statins? (2009) (83)
Polyphenols: Potential Use in the Prevention and Treatment of Cardiovascular Diseases. (2018) (82)
PCSK9 and inflammation: a review of experimental and clinical evidence. (2019) (82)
Effect of statins on toll‐like receptors: a new insight to pleiotropic effects (2018) (82)
Metabolic syndrome and renal disease. (2013) (81)
Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trials. (2020) (80)
Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate (2016) (79)
Blood Pressure, Antihypertensive Polypharmacy, Frailty, and Risk for Serious Fall Injuries Among Older Treated Adults With Hypertension (2017) (79)
Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies (2016) (79)
Safety of red yeast rice supplementation: A systematic review and meta‐analysis of randomized controlled trials (2019) (77)
A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence. (2017) (77)
Repositioning of the global epicentre of non-optimal cholesterol (2020) (77)
Macrophage plasticity, polarization and function in response to curcumin, a diet-derived polyphenol, as an immunomodulatory agent. (2019) (75)
Prevalence of childhood and adolescent overweight and obesity in Asian countries: a systematic review and meta-analysis (2018) (75)
Association of systolic blood pressure levels with cardiovascular events and all-cause mortality among older adults taking antihypertensive medication. (2014) (73)
Effects of flaxseed supplements on blood pressure: A systematic review and meta-analysis of controlled clinical trial. (2016) (72)
Lipids, blood pressure, kidney – what was new in 2011? (2011) (72)
Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants (2018) (70)
The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis (2020) (70)
The role of nutraceuticals in the prevention of cardiovascular disease. (2017) (69)
Effects of statins on mitochondrial pathways (2021) (69)
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. (2014) (69)
PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016 (2016) (69)
Subfractions and subpopulations of HDL: an update. (2014) (69)
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) (2021) (68)
Predictors of paroxysmal atrial fibrillation in patients undergoing aortic valve replacement. (2007) (68)
Serum concentrations of adiponectin, leptin, resistin, ghrelin and insulin and their association with obesity indices in obese normo- and hypertensive patients – pilot study (2012) (68)
Statin therapy and new-onset diabetes: molecular mechanisms and clinical relevance. (2013) (68)
Unrealistic Optimism in the Time of Coronavirus Pandemic: May It Help to Kill, If So—Whom: Disease or the Person? (2020) (68)
Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease. (2018) (68)
Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic (2020) (67)
Should low high-density lipoprotein cholesterol (HDL-C) be treated? (2014) (67)
Blood serum levels of IL-2, IL-6, IL-8, TNF-alpha and IL-1beta in patients on maintenance hemodialysis. (2006) (67)
Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality. (2014) (66)
Inclisiran-New hope in the management of lipid disorders? (2019) (66)
Lipid, blood pressure and kidney update 2013 (2014) (65)
Postoperative atrial fibrillation - what do we really know? (2010) (64)
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 (2021) (64)
Lone atrial fibrillation: what do we know? (2009) (64)
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 (2022) (64)
Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults (2013) (64)
A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? (2013) (63)
The role of polyphenols in cardiovascular disease. (2010) (63)
Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditions (2018) (63)
Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized controlled trials (2015) (63)
High density lipoprotein cholesterol and cancer: Marker or causative? (2018) (62)
Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study (2018) (61)
Statin-associated myopathy and the quest for biomarkers: can we effectively predict statin-associated muscle symptoms? (2017) (61)
Effects of selected dietary constituents on high-sensitivity C-reactive protein levels in U.S. adults (2018) (61)
The meaning of hypokalemia in heart failure. (2012) (61)
Clinical approach to the inflammatory etiology of cardiovascular diseases (2020) (61)
Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials. (2016) (60)
Plasma Endothelin-1 Levels in Septic Patients (2007) (60)
Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3 (2020) (60)
Blood Serum Levels of IL-2, IL-6, IL-8, TNF-α and IL-1β in Patients on Maintenance Hemodialysis (2006) (59)
C-reactive Protein Is Associated With Prevalence of the Metabolic Syndrome, Hypertension, and Diabetes Mellitus in US Adults (2018) (59)
Quercetin and metabolic syndrome: A review (2021) (59)
Particulate matter pollution and the COVID-19 outbreak: results from Italian regions and provinces (2020) (58)
Lipoprotein(a): A missing culprit in the management of athero‐thrombosis? (2018) (58)
Complications of Diabetes (2015) (58)
Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: Preliminary results (2011) (58)
Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis (2018) (58)
Impact of L-carnitine on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled trials (2016) (57)
Dietary inflammatory index and cardiometabolic risk in US adults. (2018) (57)
Designing Futuristic Telemedicine Using Artificial Intelligence and Robotics in the COVID-19 Era (2020) (57)
Contrasting Cholesterol Management Guidelines for Adults with CKD. (2015) (57)
Changes in circulating pro-protein convertase subtilisin/kexin type 9 levels – experimental and clinical approaches with lipid-lowering agents (2019) (57)
Preoperative n-3 Polyunsatured Fatty Acids Are Associated With a Decrease in the Incidence of Early Atrial Fibrillation Following Cardiac Surgery (2010) (57)
Detection of infectious agents by polymerase chain reaction in human aortic wall. (2008) (57)
Botanicals and phytochemicals active on cognitive decline: The clinical evidence (2017) (57)
Is Blood Pressure Control for Stroke Prevention the Correct Goal?: The Lost Opportunity of Preventing Hypertension (2015) (57)
Epidemiology of facial fractures: incidence, prevalence and years lived with disability estimates from the Global Burden of Disease 2017 study (2020) (56)
The Clinical Manifestation of Myocardial Infarction in Elderly Patients (2009) (56)
Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of head-to-head randomized controlled trials (2017) (56)
The link between insulin resistance parameters and serum uric acid is mediated by adiposity. (2017) (56)
Head-to-head comparison of statins versus fibrates in reducing plasma fibrinogen concentrations: A systematic review and meta-analysis. (2016) (56)
Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey. (2016) (56)
Preoperative statin therapy is not associated with a decrease in the incidence of delirium after cardiac operations. (2012) (55)
Intensive LDL‐cholesterol lowering therapy and neurocognitive function (2017) (54)
Cardiac complications associated with trastuzumab in the setting of adjuvant chemotherapy for breast cancer overexpressing human epidermal growth factor receptor type 2 – a prospective study (2012) (54)
PCSK9 inhibition - a novel mechanism to treat lipid disorders? (2013) (53)
Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis (2020) (53)
Prevalence of statin intolerance: a meta-analysis (2022) (53)
Malignancy-Associated Dyslipidemia (2011) (53)
Statin therapy in the elderly: a review. (2010) (53)
Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force. (2021) (52)
MicroRNAs: Novel Molecular Targets and Response Modulators of Statin Therapy. (2018) (52)
Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17 (2020) (52)
Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview (2018) (51)
Molecular mechanisms of statin intolerance (2016) (51)
Predictors of Insulin Resistance in Patients With Obesity (2014) (51)
An update on biomarkers of heart failure in hypertensive patients (2012) (51)
Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic (2020) (50)
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease. (2015) (50)
LDL-C: lower is better for longer—even at low risk (2020) (50)
Lipids, blood pressure and kidney update 2015 (2015) (50)
The Rise and Fall of Hypertension: Lessons Learned from Eastern Europe (2011) (50)
Markers of increased cardiovascular risk in patients with chronic kidney disease (2014) (50)
The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP). (2020) (50)
Effectiveness of Curcumin on Outcomes of Hospitalized COVID-19 Patients: A Systematic Review of Clinical Trials (2022) (49)
Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2022) (49)
Hypertension therapy in the older adults—do we know the answers to all the questions? The status after publication of the ACCF/AHA 2011 expert consensus document on hypertension in the elderly (2012) (49)
Vitamin D deficiency and non-lipid biomarkers of cardiovascular risk (2017) (49)
Circadian changes in the hemostatic system in healthy men and patients with cardiovascular diseases. (2009) (49)
The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy. (2009) (49)
Effect of Statin Therapy on Arterial Wall Inflammation Based on 18F-FDG PET/CT: A Systematic Review and Meta-Analysis of Interventional Studies (2019) (48)
Defining the Role of Trimetazidine in the Treatment of Cardiovascular Disorders: Some Insights on Its Role in Heart Failure and Peripheral Artery Disease (2014) (48)
Effect of garlic on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled clinical trials. (2016) (48)
PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021 (2021) (48)
Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 (2020) (47)
What is the association of lipid levels and incident stroke? (2016) (47)
The Role of Polymorphisms Within Paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the Modulation of Cardiovascular Risk: A Pilot Study (2010) (47)
Left atrial size in hypertension and stroke (2011) (47)
Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017 (2020) (47)
The effects of cinnamon supplementation on blood lipid concentrations: A systematic review and meta-analysis. (2017) (47)
Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: a systematic review and meta-analysis (2021) (47)
HDL abnormalities in familial hypercholesterolemia: Focus on biological functions. (2017) (47)
Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications (2019) (47)
Lipid-modifying activity of curcuminoids: A systematic review and meta-analysis of randomized controlled trials (2019) (47)
Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050 (2021) (46)
Curcumin: An effective adjunct in patients with statin‐associated muscle symptoms? (2016) (46)
Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2018) (46)
HDL functionality in type 1 diabetes. (2017) (46)
Tibolone decreases Lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patients. (2015) (46)
Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels. (2011) (45)
Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases – Some answers and still many questions (2016) (45)
Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis (2019) (45)
Hypercholesterolaemia – practical information for non-specialists (2017) (44)
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence (2014) (44)
Mapping routine measles vaccination in low- and middle-income countries (2020) (44)
The effects of statins on blood pressure in normotensive or hypertensive subjects--a meta-analysis of randomized controlled trials. (2013) (44)
Expert opinion: the therapeutic challenges faced by statin intolerance (2016) (44)
The significance of preoperative atrial fibrillation in patients undergoing cardiac surgery: preoperative atrial fibrillation--still underestimated opponent. (2008) (44)
Combination lipid-lowering therapy as first-line strategy in very high-risk patients. (2021) (44)
Predictive factors for endoleaks after thoracic aortic aneurysm endograft repair. (2009) (43)
OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP). (2021) (43)
Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy? (2020) (43)
Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. (2013) (43)
Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2022) (43)
Clinical implications of the IMPROVE-IT trial in the light of current and future lipid-lowering treatment options (2016) (42)
Neutrophil Superoxide Anion Generation During Atorvastatin and Fluvastatin Therapy Used in Coronary Heart Disease Primary Prevention (2006) (42)
Effects of supplementation with green tea catechins on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials. (2015) (42)
Healthy lifestyle factors and incident heart disease and mortality in candidates for primary prevention with statin therapy. (2016) (42)
What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER? (2019) (42)
Consumption of dairy product and its association with total and cause specific mortality - A population-based cohort study and meta-analysis. (2019) (42)
Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2021) (42)
Discussion around statin discontinuation in older adults and patients with wasting diseases (2016) (42)
The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2020) (42)
Obesity indices and adipokines in non-diabetic obese patients with early stages of chronic kidney disease (2013) (41)
Statins: Then and Now. (2019) (41)
Mineral and vitamin consumption and telomere length among adults in the United States. (2017) (41)
[Prevention and treatment of atrial fibrillation following cardiac surgery]. (2005) (41)
Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials. (2020) (41)
HSP 70 and atherosclerosis--protector or activator? (2009) (40)
Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials (2013) (40)
Egg Consumption and Risk of Total and Cause-Specific Mortality: An Individual-Based Cohort Study and Pooling Prospective Studies on Behalf of the Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group (2019) (40)
Natriuretic peptides in cardiovascular diseases (2008) (40)
Curcumin: A Naturally Occurring Modulator of Adipokines in Diabetes (2017) (40)
Combined dyslipidemia: should the focus be LDL cholesterol or atherogenic dyslipidemia? (2013) (40)
Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis (2017) (40)
Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison With Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol: The Very Large Database of Lipids Study (VLDL-2B). (2015) (40)
ETC-1002: a future option for lipid disorders? (2014) (39)
Atrial fibrillation as a nonpsychiatric predictor of delirium after cardiac surgery: a pilot study. (2008) (39)
Evaluating bempedoic acid for the treatment of hyperlipidaemia (2017) (39)
Clinical utility and use of DSM-IV and ICD-10 Criteria and The Memorial Delirium Assessment Scale in establishing a diagnosis of delirium after cardiac surgery. (2008) (39)
Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial). (2010) (39)
Dietary food patterns and glucose/insulin homeostasis: a cross-sectional study involving 24,182 adult Americans (2017) (39)
Heart failure biomarkers in patients with dilated cardiomyopathy. (2013) (39)
Plasma Total Antioxidant Activity in Comparison With Plasma NO and VEGF Levels in Patients With Metabolic Syndrome (2009) (39)
Effects of immunization against PCSK9 in an experimental model of breast cancer (2019) (39)
PCSK9: a view beyond the canonical cholesterol lowering impact. (2021) (38)
Exosomes as nanocarriers for siRNA delivery: paradigms and challenges (2016) (38)
Heart function disturbances in chronic kidney disease – echocardiographic indices (2014) (37)
Resveratrol: Mechanistic and Therapeutic Perspectives in Pulmonary Arterial Hypertension. (2020) (37)
Novel therapeutic strategies for stroke: The role of autophagy (2019) (37)
Effect of magnesium supplements on serum C-reactive protein: a systematic review and meta-analysis (2018) (37)
Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study (2022) (37)
Role and significance of statins in the treatment of hypertensive patients (2009) (37)
Prevention of heart failure in older adults may require higher levels of physical activity than needed for other cardiovascular events. (2013) (36)
The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 (2021) (36)
Management of familial hypercholesterolemia in children and adolescents. Position paper of the Polish Lipid Expert Forum. (2014) (36)
Associations between cardiovascular disease, cancer, and very low high-density lipoprotein cholesterol in the REasons for Geographical and Racial Differences in Stroke (REGARDS) study (2018) (36)
Ferumoxytol: a new era of iron deficiency anemia treatment for patients with chronic kidney disease. (2011) (36)
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study (2015) (36)
Relation between postoperative mortality and atrial fibrillation before surgical revascularization--3-year follow-up. (2008) (36)
The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019 (2022) (36)
The Yin and Yang of carbon nanomaterials in atherosclerosis. (2018) (35)
High-Density Lipoprotein Components and Functionality in Cancer: State-of-the-Art (2019) (35)
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels? (2021) (35)
Statins and new-onset diabetes. (2014) (35)
Lipid-modifying effects of krill oil in humans: systematic review and meta-analysis of randomized controlled trials (2017) (35)
Atrial Fibrillation: The New Epidemic of the Ageing World. (2009) (35)
Statins and C-reactive protein: in silico evidence on direct interaction (2020) (35)
New Obesity Indices and Adipokines in Normotensive Patients and Patients With Hypertension (2014) (35)
Telomere Length Is Associated With Cardiometabolic Factors in US Adults (2017) (35)
Assessment of the Relationship between Lipid Parameters and Obesity Indices in Non-Diabetic Obese Patients: A Preliminary Report (2014) (35)
National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries (2019) (35)
Red blood cell transfusion is a determinant of neurological complications after cardiac surgery. (2015) (35)
PCSK9 and diabetes: is there a link? (2017) (35)
The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension (2015) (34)
High‐Sensitivity C‐Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study (2020) (34)
Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases - A position paper from the International Lipid Expert Panel (ILEP). (2021) (34)
Nutraceuticals as an Important Part of Combination Therapy in Dyslipidaemia. (2017) (34)
Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone (2020) (34)
Recent perspectives on the role of nutraceuticals as cholesterol-lowering agents (2017) (34)
Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation. (2013) (34)
Lipoprotein (a)—We Know So Much Yet Still Have Much to Learn … (2016) (33)
Lipoprotein(a) Levels in Patients With Abdominal Aortic Aneurysm (2017) (33)
Serum metalloproteinases MMP-2, MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in patients on hemodialysis (2011) (33)
What should be the optimal levels of blood pressure: does the J-curve phenomenon really exist? (2011) (33)
2020 Guidelines of the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA) on laboratory diagnostics of lipid metabolism disorders (2020) (33)
Antitumor effects of curcumin: A lipid perspective (2019) (33)
Red Yeast Rice for Hypercholesterolemia. (2019) (33)
Nutraceutical support in heart failure: a position paper of the International Lipid Expert Panel (ILEP) (2020) (33)
Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials (2018) (33)
Ten most important things to learn from the ACCF/AHA 2011 expert consensus document on hypertension in the elderly (2012) (33)
Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines (2018) (32)
Genetic determinants of cardiovascular disease: the renin-angiotensin-aldosterone system, paraoxonases, endothelin-1, nitric oxide synthase and adrenergic receptors. (2009) (32)
Clinical research Serum concentrations of adiponectin, leptin, resistin, ghrelin and insulin and theirassociation with obesity indices in obese normo- and hypertensive patients – pilot study (2012) (32)
Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysis. (2017) (32)
Accuracy of low-density lipoprotein cholesterol estimation at very low levels (2017) (32)
Targeting AMPK by Statins: A Potential Therapeutic Approach (2021) (32)
Effects of Allopurinol on Endothelial Function: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials (2017) (32)
Endothelial Dysfunction in Patients with Noncomplicated and Complicated Hypertension (2009) (32)
ETC-1002 (Bempedoic acid) for the management of hyperlipidemia: from preclinical studies to phase 3 trials (2019) (32)
Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials (2018) (32)
Global trends of hand and wrist trauma: a systematic analysis of fracture and digit amputation using the Global Burden of Disease 2017 Study (2020) (32)
Effects of Atorvastatin on Vascular Intimal Hyperplasia: An Experimental Rodent Model (2009) (32)
Nephroprotective and clinical potential of statins in dialyzed patients. (2009) (32)
Prevention of sudden cardiac death in patients with chronic kidney disease (2012) (32)
The potential role of plant-derived natural products in improving arterial stiffness: A review of dietary intervention studies (2020) (31)
Lipoprotein(a) and inhibitors of proprotein convertase subtilisin/kexin type 9. (2017) (31)
Editorial: Telemedicine During and Beyond COVID-19 (2021) (31)
Statin Intolerance: Some Practical Hints. (2018) (31)
Sleep changes following statin therapy: a systematic review and meta-analysis of randomized placebo-controlled polysomnographic trials (2015) (31)
Effects of coenzyme Q10 supplementation on activities of selected antioxidative enzymes and lipid peroxidation in hypertensive patients treated with indapamide. A pilot study (2010) (31)
Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension (2014) (31)
HSP 70 and atherosclerosis – protector or activator? (2009) (31)
Statin use and risk of diabetes mellitus in postmenopausal women (2012) (31)
Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study (2016) (30)
Effects of Coenzyme Q 10 on Statin-Induced Myopathy : A Meta-analysis of Randomized Controlled Trials (2014) (30)
Current problems in hypertension and nephrology (2010) (30)
Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight (2020) (30)
Ticagrelor--a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors? (2009) (30)
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study (2019) (30)
Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels. (2020) (30)
Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies. (2016) (30)
Novel Therapeutic Targets for Managing Dyslipidemia. (2018) (30)
PCSK9 and neurocognitive function: Should it be still an issue after FOURIER and EBBINGHAUS results? (2018) (29)
Predictors of atrial fibrillation in patients following isolated surgical revascularization. A metaanalysis of 9 studies with 28 786 patients (2007) (29)
Subclinical hypothyroidism and the development of heart failure: an overview of risk and effects on cardiac function (2018) (29)
Comparison of clinical outcomes between bioresorbable vascular stents versus conventional drug-eluting and metallic stents: a systematic review and meta-analysis. (2016) (29)
Telomere attrition, kidney function, and prevalent chronic kidney disease in the United States (2017) (29)
Hybrid comprehensive telerehabilitation in heart failure patients (TELEREH-HF): A randomized, multicenter, prospective, open-label, parallel group controlled trial-Study design and description of the intervention. (2019) (29)
Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials (2016) (29)
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. (2016) (29)
The potential role of statins in preeclampsia and dyslipidemia during gestation: a narrative review (2018) (28)
Association of types of dietary fats and all-cause and cause-specific mortality: A prospective cohort study and meta-analysis of prospective studies with 1,148,117 participants. (2020) (28)
An evaluation of RVX-208 for the treatment of atherosclerosis (2015) (28)
Hydrophilic vs lipophilic statins in coronary artery disease: A meta-analysis of randomized controlled trials. (2017) (28)
PCSK9 immunization using nanoliposomes: preventive efficacy against hypercholesterolemia and atherosclerosis (2021) (28)
Prognostic value of coronary artery calcium score, area, and density among individuals on statin therapy vs. non-users: The coronary artery calcium consortium. (2020) (28)
An overview of statin-induced myopathy and perspectives for the future (2020) (28)
The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy – 5-year follow-up (2013) (28)
Blood Pressure Levels and Stroke: J-curve Phenomenon? (2013) (28)
Sudden cardiac death in CKD patients (2015) (28)
Statins in patients with chronic kidney disease: why, who and when? (2010) (27)
Complex relationship of obesity and obesity paradox in heart failure – higher risk of developing heart failure and better outcomes in established heart failure (2016) (27)
Hypertension and kidney disease: is renalase a new player or an innocent bystander? (2012) (27)
Resveratrol effect on patients with non‐alcoholic fatty liver disease: A matter of dose and treatment length (2018) (27)
Resveratrol and cognitive decline: a clinician perspective (2019) (27)
Elevated cholesterol reduces acetylsalicylic acid-mediated platelet acetylation. (2007) (27)
Association between telomere length and complete blood count in US adults (2017) (27)
Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level (2014) (27)
Pathophysiology of Cardiovascular Complications in COVID-19 (2020) (26)
The Current Use and Evolving Landscape of Nutraceuticals (2021) (26)
Incretin-based therapies, glucometabolic health and endovascular inflammation. (2014) (26)
Subnational mapping of HIV incidence and mortality among individuals aged 15–49 years in sub-Saharan Africa, 2000–18: a modelling study (2021) (26)
Current place of beta-blockers in the treatment of hypertension. (2010) (26)
Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer (2019) (26)
Effects of coenzyme Q10 supplementation on plasma C‐reactive protein concentrations: A systematic review and meta‐analysis of randomized controlled trials (2017) (26)
MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia? (2017) (26)
Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019 (2021) (26)
Immunological aspects of the statins' function in patients with heart failure: a report from the Annual Conference of ESC - Heart Failure 2005. (2005) (26)
The effect of timing of cardiac catheterization on acute kidney injury after cardiac surgery is influenced by the type of operation. (2014) (26)
Efficacy of remote ischaemic preconditioning for spinal cord protection against ischaemic injury: association with heat shock protein expression. (2008) (26)
Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis (2016) (25)
Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease (2013) (25)
Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease (2013) (25)
The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion. (2019) (25)
Atrial and Brain Natriuretic Peptide and Endothelin-1 Concentration in Patients with Idiopathic Arterial Hypertension: The Dependence on the Selected Morphological Parameters (2007) (25)
Increased Levels of Soluble TNF-α Receptors and Cellular Adhesion Molecules in Patients Undergoing Bioincompatible Hemodialysis (2006) (25)
Associations between risk of overall mortality, cause-specific mortality and level of inflammatory factors with extremely low and high high-density lipoprotein cholesterol levels among American adults. (2019) (24)
PCSK9 and infection: A potentially useful or dangerous association? (2018) (24)
What do we know about the role of lipoprotein(a) in atherogenesis 57 years after its discovery? (2020) (24)
Application of nanotechnology to improve the therapeutic benefits of statins. (2019) (24)
Comparing different assessments of remnant lipoprotein cholesterol: The very large database of lipids. (2019) (24)
Atherogenic versus non-atherogenic lipoprotein profiles in healthy individuals. is there a need to change our approach to diagnosing dyslipidemia? (2014) (24)
Predictive Value for Galectin 3 and Cardiotrophin 1 in Hemodialysis Patients (2016) (24)
Modulation of microRNAs by aspirin in cardiovascular disease. (2020) (24)
Is Polymorphism Within eNOS Gene Associated With the Late Onset of Myocardial Infarction? A Pilot Study (2009) (24)
Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019 (2021) (23)
Dietary natural products as emerging lipoprotein(a)‐lowering agents (2019) (23)
The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: Results from the TERCET registry with 19,781 individuals. (2019) (23)
Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 (2022) (23)
Statins and autoimmunity: State-of-the-art. (2020) (23)
Is type 2 diabetes mellitus a coronary heart disease equivalent or not? Do not just enjoy the debate and forget the patient! (2019) (23)
Novel approaches toward the generation of bioscaffolds as a potential therapy in cardiovascular tissue engineering. (2017) (23)
A higher flavonoid intake is associated with less likelihood of nonalcoholic fatty liver disease: results from a multiethnic study. (2019) (23)
Impact of ursodeoxycholic acid on circulating lipid concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials (2019) (23)
Dietary patterns, plasma vitamins and Trans fatty acids are associated with peripheral artery disease (2017) (23)
Are two drugs better than one? A review of combination therapies for hypertension (2017) (23)
Impact of Statin Therapy on Plasma MMP-3, MMP-9, and TIMP-1 Concentrations: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials (2017) (22)
The use of DSM-IV and ICD-10 criteria and diagnostic scales for delirium among cardiac surgery patients: results from the IPDACS study. (2010) (22)
Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and function. (2015) (22)
Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention Study (2020) (22)
The effect of statins on cardiovascular outcomes by smoking status: A systematic review and meta‐analysis of randomized controlled trials (2017) (22)
Lipid-lowering therapies and achievement of LDL-cholesterol targets (2012) (22)
Are we getting to lipid targets in real life? (2010) (22)
Effect of atorvastatin on delirium status of patients in the intensive care unit: a randomized controlled trial (2019) (22)
Acute coronary syndromes in patients with chronic kidney disease. (2013) (22)
Changes in disease burden in Poland between 1990–2017 in comparison with other Central European countries: A systematic analysis for the Global Burden of Disease Study 2017 (2020) (22)
Characteristics of lipid profile and effectiveness of management of dyslipidaemia in patients with acute coronary syndromes – Data from the TERCET registry with 19,287 patients (2019) (22)
Statins as anti-pyroptotic agents (2021) (22)
Effect of fibrates on glycemic parameters: A systematic review and meta‐analysis of randomized placebo‐controlled trials (2017) (22)
Proprotein Convertase Subtilisin/Kexin 9 Inhibitors (2015) (22)
Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study. (2017) (21)
Effect of methoxy polyethylene glycol-epoetin beta on oxidative stress in predialysis patients with chronic kidney disease (2013) (21)
Higher dietary acid load is associated with higher likelihood of peripheral arterial disease among American adults. (2018) (21)
Bioresorbable scaffold - A magic bullet for the treatment of coronary artery disease? (2016) (21)
A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients. (2016) (21)
Dysfunctional HDL: the journey from savior to slayer (2014) (21)
Isolated diastolic hypertension and incident heart failure in community-dwelling older adults: Insights from the Cardiovascular Health Study. (2017) (21)
Foam Cells as Therapeutic Targets in Atherosclerosis with a Focus on the Regulatory Roles of Non-Coding RNAs (2021) (21)
Statins and LDL-C in Secondary Prevention-So Much Progress, So Far to Go. (2020) (21)
Renalase, Hypertension, and Kidney — The Discussion Continues (2012) (21)
A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome. (2019) (21)
Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients (2016) (21)
Association of ideal cardiovascular health metrics with serum uric acid, inflammation and atherogenic index of plasma: A population-based survey. (2019) (21)
Can we change the functionality of HDL cholesterol with nonpharmacological and pharmacological agents? (2014) (21)
Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019 (2021) (20)
Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17 (2020) (20)
Association between phenotypic familial hypercholesterolaemia and telomere length in US adults: results from a multi-ethnic survey (2018) (20)
Associations of serum uric acid with total and cause-specific mortality: Findings from individuals and pooling prospective studies. (2019) (20)
Improved COVID-19 Outcomes following Statin Therapy: An Updated Systematic Review and Meta-analysis (2021) (20)
Statins, haemostatic factors and thrombotic risk (2017) (20)
Side effects of statins-from pathophysiology and epidemiology to diagnostic and therapeutic implications. (2022) (20)
A review of gene‐ and cell‐based therapies for familial hypercholesterolemia (2019) (20)
Evaluation of selected parameters of the antioxidative system in patients with type 2 diabetes in different periods of metabolic compensation (2007) (20)
Editorial [Hot topic: Controversies in Hypertension Treatment (Guest Editors: Maciej Banach, Sverre E. Kjeldsen and Krzysztof Narkiewicz)] (2010) (20)
Effect of dipeptidyl peptidase-4 inhibitors on circulating tumor necrosis factor-α concentrations: A systematic review and meta-analysis of controlled trials. (2017) (20)
Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP) (2022) (20)
The Use of Plant Sterols and Stanols as Lipid-Lowering Agents in Cardiovascular Disease. (2017) (20)
Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP) (2022) (20)
Parenteral systems for statin delivery: a review (2019) (20)
The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis (2017) (20)
Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 (2021) (20)
Dronedarone: An overview (2012) (20)
The influence of hypoxic physical activity on cfDNA as a new marker of vascular inflammation (2015) (20)
Mapping inequalities in exclusive breastfeeding in low- and middle-income countries, 2000–2018 (2021) (19)
The Role of Protein SUMOylation in the Pathogenesis of Atherosclerosis (2019) (19)
The role of trimetazidine after acute myocardial infarction. (2008) (19)
Fetal toxicity associated with statins: A systematic review and meta-analysis. (2021) (19)
The effects of liraglutide on glucose, inflammatorymarkersandlipoprotein metabolism: current knowledge and future perspective (2013) (19)
N-terminal brain natriuretic propeptide levels correlate with procalcitonin and C-reactive protein levels in septic patients (2006) (19)
Relationship between long noncoding RNAs and physiological risk factors of cardiovascular disease. (2017) (19)
Fibrinogen and Atherosclerotic Cardiovascular Diseases—Review of the Literature and Clinical Studies (2021) (19)
Effect of soy isoflavone supplementation on plasma lipoprotein(a) concentrations: A meta-analysis. (2017) (19)
The Effect of Caloric Restriction and Fasting on Cancer. (2020) (18)
Risk factors for atrial fibrillation in adult patients in long-term observation following surgical closure of atrial septal defect type II. (2006) (18)
Fibroblast growth factor 19-targeted therapies for the treatment of metabolic disease (2015) (18)
Prosarcopenic Effects of Statins May Limit Their Effectiveness in Patients with Heart Failure. (2018) (18)
Raloxifene Lowers Plasma Lipoprotein(a) Concentrations: a Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials (2017) (18)
Effect of Atorvastatin on Low-Density Lipoprotein Subpopulations and Comparison Between Indicators of Plasma Atherogenicity (2014) (18)
Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis (2019) (18)
The International Natural Product Sciences Taskforce (INPST) and the power of Twitter networking exemplified through #INPST hashtag analysis. (2022) (18)
Statins and dilated cardiomyopathy: do we have enough data? (2011) (18)
Regulation of efferocytosis by caspase-dependent apoptotic cell death in atherosclerosis. (2020) (18)
Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 (2022) (18)
COVID-19 and cardiovascular complications – preliminary results of the LATE-COVID study (2021) (18)
[The role of inflammation in the pathogenesis of atherosclerosis]. (2004) (18)
Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials. (2018) (18)
Does coffee consumption alter plasma lipoprotein(a) concentrations? A systematic review (2018) (18)
Nocebo/drucebo effect in statin-intolerant patients: an attempt at recommendations. (2021) (17)
Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study (2018) (17)
Adhering to the principles of clinical pharmacology - the correct fixed combinations of antihypertensive drugs (2018) (17)
HDL functionality in familial hypercholesterolemia: effects of treatment modalities and pharmacological interventions. (2018) (17)
Interaction Between Coronavirus S-Protein and Human ACE2: Hints for Exploring Efficient Therapeutic Targets to Treat COVID-19 (2020) (17)
Heart Rate Control in an Unselected Consecutive Population of Outpatients With Stable Coronary Artery Disease: Analysis of the CARDIf Study Cohort (2010) (17)
Decompensated Heart Failure and Renal Failure: What Is the Current Evidence? (2018) (17)
IMPROVE-IT: what have we learned? (2016) (17)
Vernakalant hydrochloride for the treatment of atrial fibrillation (2009) (17)
PCSK9 inhibitors in sepsis: a new potential indication? (2017) (17)
Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2 (2020) (17)
Increased whole blood chemiluminescence in patients with chronic renal failure independent of hemodialysis treatment (2006) (17)
Statins in the prevention of postoperative atrial fibrillation: is there really no effect? (2008) (17)
Echocardiographic evaluation of the left atrium and left atrial appendage function in patients with atrial septum aneurysm: implications for thromboembolic complications. (2007) (17)
Evaluation of dyslipidaemia and the impact of hypolipidemic therapy on prognosis in high and very high risk patients through the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) Registry (2017) (17)
Pulse wave velocity as a measure of arterial stiffness in patients with familial hypercholesterolemia: a systematic review and meta-analysis (2019) (17)
Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge (2015) (16)
How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors. (2020) (16)
Do HDL and LDL subfractions play a role in atherosclerosis in end-stage renal disease (ESRD) patients? (2016) (16)
Practical issues in clinical scenarios involving CKD patients requiring antithrombotic therapy in light of the 2017 ESC guideline recommendations (2018) (16)
Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta‐analysis of randomized controlled trials (2021) (16)
Novel Therapeutical Approaches to Managing Atherosclerotic Risk (2021) (16)
The quest for equilibrium: exploring the thin red line between bleeding and ischaemic risks in the management of acute coronary syndromes in chronic kidney disease patients (2017) (16)
Current research in biotechnology: Exploring the biotech forefront (2019) (16)
Effect of Evolocumab on Non‐High‐Density Lipoprotein Cholesterol, Apolipoprotein B, and Lipoprotein(a): A Pooled Analysis of Phase 2 and Phase 3 Studies (2020) (16)
Statins and the risk of diabetes: the debate. (2012) (16)
Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum. (2013) (16)
HDL and cancer - causality still needs to be confirmed? Update 2020. (2020) (16)
The Use of DSM-IV and ICD-10 Criteria and Diagnostic Scales for Delirium Among Cardiac Surgery Patients: Results From the IPDACS Study (2010) (16)
Worldwide Dyslipidemia Guidelines (2019) (16)
Synthesis, Chemical Characterization and Multiscale Biological Evaluation of a Dimeric-cRGD Peptide for Targeted Imaging of αVβ3 Integrin Activity (2017) (16)
Medication Management of Chronic Heart Failure in Older Adults (2013) (16)
Controversies in hypertension treatment. (2010) (16)
Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applications (2017) (16)
Effects of statins on myocarditis: A review of underlying molecular mechanisms. (2021) (16)
The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction (2017) (16)
We are infected with the new, mutated virus UO-COVID-19 (2020) (16)
Prevalence and impact of diabetes in hospitalized COVID‐19 patients: A systematic review and meta‐analysis (2021) (16)
Erythropoietin update 2011 (2011) (15)
Embracing the polypill as a cardiovascular therapeutic: is this the best strategy? (2018) (15)
The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease. (2016) (15)
Right ventricular ejection fraction <20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients. (2012) (15)
Link between plasma trans-fatty acid and fatty liver is moderated by adiposity. (2018) (15)
Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials (2022) (15)
The interaction of Helicobacter pylori with cancer immunomodulatory stromal cells: new insight into gastric cancer pathogenesis. (2021) (15)
Natriuretic peptides in septic patients. (2009) (15)
Lipid-lowering agents for concurrent cardiovascular and chronic kidney disease (2019) (15)
Association between plasma trans fatty acids concentrations and leucocyte telomere length in US adults (2018) (15)
The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy via the Modulation of Inflammatory Milieu (2019) (15)
The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study. (2020) (15)
RNA Silencing in the Management of Dyslipidemias (2021) (15)
Beneficial effects of pre-stroke statins use in cardioembolic stroke patients with atrial fibrillation: a hospital-based retrospective analysis (2019) (15)
TNF-α priming effect on polymorphonuclear leukocyte reactive oxygen species generation and adhesion molecule expression in hemodialyzed patients (2006) (14)
Optimal timing of discontinuation of clopidogrel and risk of blood transfusion after coronary surgery. Propensity score analysis. (2011) (14)
Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7 (2019) (14)
Obesity indices and inflammatory markers in obese non-diabetic normo- and hypertensive patients: a comparative pilot study (2014) (14)
Assessment of blood flow in posterior ciliary arteries and its correlation with intraocular and arterial blood pressures in patients with open angle glaucoma. (2010) (14)
Statin Use in COVID-19 Hospitalized Patients and Outcomes: A Retrospective Study (2022) (14)
A high consumption of tomato and lycopene is associated with a lower risk of cancer mortality: results from a multi-ethnic cohort (2020) (14)
The concentration of atrial and brain natriuretic peptide in patients with idiopathic hypertension. (2007) (14)
The Relationship between COVID-19 and Hypothalamic–Pituitary–Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess—The CAPISCO International Expert Panel (2022) (14)
Carvedilol modifies antioxidant status of patients with stable angina (2008) (14)
Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study. (2020) (14)
Endothelial dysfunction in dyslipidaemia: Molecular mechanisms and clinical implications. (2019) (14)
Association between heart rate at rest and myocardial perfusion in patients with acute myocardial infarction undergoing cardiac rehabilitation – a pilot study (2012) (14)
The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia (2020) (14)
Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum. (2013) (14)
Polypills for the prevention of Cardiovascular diseases (2016) (14)
Adoption of the ADA/EASD guidelines in 10 Eastern and Southern European countries: physician survey and good clinical practice recommendations from an International Expert Panel. (2020) (14)
PCSK9 vaccine: so near, yet so far! (2021) (14)
The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland. (2018) (14)
The prevalence of onchocerciasis in Africa and Yemen, 2000–2018: a geospatial analysis (2022) (14)
Renalase is removed by kidneys and during dialysis - excess related to CKD complications? (2015) (14)
Lipid-lowering therapies: Better together. (2021) (14)
The potential role of mitochondrial ATP synthase inhibitory factor 1 (IF1) in coronary heart disease: a literature review (2017) (14)
Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology (2013) (13)
Physical Exercise and DNA Injury: Good or Evil? (2017) (13)
Tomato and lycopene consumption is inversely associated with total and cause-specific mortality: a population-based cohort study, on behalf of the International Lipid Expert Panel (ILEP) (2019) (13)
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study (2020) (13)
Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019 (2022) (13)
Protein convertase subtilisin/kexin type 9 biology in nephrotic syndrome: implications for use as therapy. (2020) (13)
PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk. (2017) (13)
Mineral and vitamins consumption is associated with longer telomeres among US adults (2017) (13)
Statin therapy in athletes and patients performing regular intense exercise - Position Paper from the International Lipid Expert Panel (ILEP). (2020) (13)
Inverse association between serum antioxidant levels and inflammatory markers is moderated by adiposity: a report based on a large representative population sample of American adults (2018) (13)
Bleeding in advanced CKD patients on antithrombotic medication – A critical appraisal (2017) (13)
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection (2021) (13)
Lipid levels, atrial fibrillation and the impact of age: Results from the LIPIDOGRAM2015 study. (2020) (13)
The significance of statin use in patients subjected to surgical coronary revascularization (2008) (13)
Modern prevalence of dysbetalipoproteinemia (Fredrickson-Levy-Lees type III hyperlipoproteinemia) (2019) (13)
Aortic stiffness in diabetes mellitus--association with glutamine and heat shock protein 70 expression: a pilot study based on an experimental rodent model. (2009) (13)
Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study (2010) (13)
Patient-Level Discordance in Population Percentiles of the TC/HDL-C Ratio Compared with LDL-C and Non-HDL-C: The Very Large Database of Lipids Study (VLDL-2B) (2015) (13)
Bacterial infections are associated with cardiovascular disease in Iran: a meta-analysis (2019) (13)
Association Between Plasma Trans-Fatty Acid Concentrations and Measures of Glucose Homeostasis and Cardiovascular Risk Factors in Adults in NHANES 1999-2000 (2018) (12)
Pre-Clinical Evaluation of the Nanoliposomal antiPCSK9 Vaccine in Healthy Non-Human Primates (2021) (12)
Adiposity mediates the association between whole grain consumption, glucose homeostasis and insulin resistance: findings from the US NHANES (2018) (12)
Drucebo effect – the challenge we should all definitely face! (2021) (12)
The impact of argan oil on plasma lipids in humans: Systematic review and meta‐analysis of randomized controlled trials (2018) (12)
Statins and Lp(a): do not make perfect the enemy of excellent. (2019) (12)
What is the risk of hyperkalaemia in heart failure? (2011) (12)
Combination drug versus monotherapy for the treatment of autosomal dominant polycystic kidney disease (2016) (12)
Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomes. (2020) (12)
Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications (2021) (12)
Cardiac manifestations of COVID-19. (2021) (12)
Factors influencing post-coronary artery bypass grafting atrial fibrillation episodes. (2013) (12)
Effect of Cardiovascular Drugs on Adenosine Deaminase Activity (2008) (12)
Game of “crowning” season 8: RAS and reproductive hormones in COVID-19 – can we end this viral series? (2020) (11)
A systematic review and meta-analysis on the effects of statins on pregnancy outcomes. (2021) (11)
P705Step by step diagnosis and management of statin intolerance: position paper from an international lipid expert panel (2019) (11)
Does Gender Influence the Patency of Infrainguinal Bypass Grafts? (2008) (11)
Changes in circulating proprotein convertase subtilisin / kexin type 9 levels – experimental and clinical approaches with lipid-lowering agents (11)
Nephroprotective and clinical potential of statins in dialyzed patients (2009) (11)
In reply--Coenzyme Q10 and statin-induced myopathy. (2015) (11)
Statin therapy and new-onset diabetes: an attempt at recommendations (2013) (11)
Effects of immunisation against PCSK9 in mice bearing melanoma (2019) (11)
Hypertension - Current Natural Strategies to Lower Blood Pressure. (2017) (11)
Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome. (2019) (11)
Association of Empirical Dietary Atherogenic Indices with All-Cause and Cause-Specific Mortality in a Multi-Ethnic Adult Population of the United States (2019) (11)
Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia (2021) (11)
Gender differences in the treatment of ischemic heart disease. (2011) (11)
Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies (2021) (11)
L-arginine improves hemodynamic function and coronary flow in an experimental model of ischemia-reperfusion injury. (2006) (11)
Proprotein Convertase Subtilisin Kexin Type 9 (2021) (10)
[Management in familial hypercholesterolaemia in children and adolescents. Position of the Lipid Expert Forum]. (2013) (10)
Apolipoprotein B/Apolipoprotein A-I Ratio Is a Better Predictor of Cancer Mortality Compared with C-Reactive Protein: Results from Two Multi-Ethnic US Populations (2020) (10)
Epigenetic control of atherosclerosis via DNA methylation: A new therapeutic target? (2020) (10)
The optimal time of day for statin administration: a review of current evidence (2018) (10)
Cytisine - From the Past to the Future. (2019) (10)
Prognostic value of plasma N-terminal pro-B-type natriuretic peptide concentration in patients with normal and impaired left ventricular systolic function undergoing surgery for abdominal aortic aneurysm (2011) (10)
Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID‐19: Shoot the messenger! (2020) (10)
Lipids, Blood Pressure, Kidney-what was New in 2012? (2012) (10)
Dietary choline is positively related to overall and cause-specific mortality: results from individuals of the National Health and Nutrition Examination Survey and pooling prospective data (2019) (10)
Evaluation of a dimeric-cRGD peptide for targeted PET-CT imaging of peripheral angiogenesis in diabetic mice (2013) (10)
ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic Epidemiology. (2018) (10)
Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study). (2022) (10)
Statin treatment in the elderly: how much do we know? (2013) (10)
Ca2+ Flux: Searching for a Role in Efferocytosis of Apoptotic Cells in Atherosclerosis (2019) (10)
Decreased kidney function as a risk factor for cardiovascular events in subjects with metabolic syndrome - a pilot study (2008) (10)
Correlation of the severity of diabetic retinopathy and the heart muscle perfusion in patients with type 2 diabetes. (2011) (10)
Imbalance between pro-angiogenic and anti-angiogenic factors in rheumatic and mixomatous mitral valves. (2011) (10)
Adverse Impact of Desulfovibrio spp. and Beneficial Role of Anaerostipes spp. on Renal Function: Insights from a Mendelian Randomization Analysis (2020) (10)
Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe: DA VINCI observational study. (2021) (10)
A comprehensive review on the lipid and pleiotropic effects of pitavastatin. (2021) (10)
Heart remodeling induced by adjuvant trastuzumab-containing chemotherapy for breast cancer overexpressing human epidermal growth factor receptor type 2: a prospective study. (2013) (10)
Methotrexate for Cardiovascular Risk Reduction: The Right Choice? (2020) (10)
The impact of nuts consumption on glucose/insulin homeostasis and inflammation markers mediated by adiposity factors among American adults (2018) (9)
Rationale of statin therapy in septic patients. (2013) (9)
The role of statins in lung cancer (2021) (9)
Ideal cardiovascular health associated with fatty liver: Results from a multi-ethnic survey. (2019) (9)
Oxidative Stress in Women Treated with Atosiban for Impending Preterm Birth (2018) (9)
The Role of Adipokines in the Development of Arterial Stiffness and Hypertension (2020) (9)
Adiposity May Moderate the Link Between Choline Intake and Non-alcoholic Fatty Liver Disease (2019) (9)
Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studies (2020) (9)
Novel drugs for heart rate control in heart failure (2018) (9)
The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE‐AF) study (2017) (9)
Post-COVID syndrome, inflammation, and diabetes (2022) (9)
The effects of statins on blood pressure: current knowledge and future perspectives (2012) (9)
PCSK9 genetic variants and cognitive abilities: a large-scale Mendelian randomization study (2020) (9)
On the present and future role of Lp-PLA2 in atherosclerosis-related cardiovascular risk prediction and management (2020) (9)
Quality of life in heart failure patients undergoing hybrid comprehensive telerehabilitation versus usual care – results of the Telerehabilitation in Heart Failure Patients (TELEREH-HF) Randomized Clinical Trial (2020) (9)
Morphine-mediated alteration of hypertension-related gene expression in human white blood cells and multilineage progenitor cells (2010) (9)
Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) registry. (2021) (9)
Various interferon (IFN)-inducible transmembrane (IFITM) proteins for COVID-19, is there a role for the combination of mycophenolic acid and interferon? (2020) (9)
Colchicine and Cardiovascular Outcomes: a Critical Appraisal of Recent Studies (2021) (9)
An update on PCSK9 inhibitors- pharmacokinetics, drug interactions, and toxicity (2020) (9)
Effects of statins on delirium following cardiac surgery - evidence from literature. (2015) (9)
High-Density Lipoprotein and Low-Density Lipoprotein Subfractions in Patients with Chronic Kidney Disease. (2017) (9)
EDITORIAL A medium of science communication in our times (2009) (9)
A systematic review and meta-analysis of the impact of spirulina supplementation on plasma lipid concentrations (2015) (9)
Modulation of heat shock proteins by statins (2018) (9)
Clinical implications of non-invasive measurement of central aortic blood pressure. (2010) (9)
Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health (2022) (8)
Atrial Fibrillation: The New Epidemic of the Ageing World (2009) (8)
Monounsaturated Fatty Acid Levels May Not Affect Cardiovascular Events: Results From a Mendelian Randomization Analysis (2020) (8)
Protective role of nutraceuticals against myocarditis (2021) (8)
Role of Geriatric Syndromes in the Management of Atrial Fibrillation in Older Adults: A Narrative Review. (2019) (8)
Endovascular treatment of mycotic aortic aneurysms. (2008) (8)
The beneficial therapeutic effects of plant‐derived natural products for the treatment of sarcopenia (2022) (8)
Oxidative Stress Markers in Hypertrophic Cardiomyopathy (2021) (8)
Statins in patients with chronic kidney disease – an attempt at recommendations (2013) (8)
Serum lipophilic antioxidants levels are associated with leucocyte telomere length among US adults (2018) (8)
The major molecular mechanisms mediating the renoprotective effects of SGLT2 inhibitors: An update (2019) (8)
The Knowledge and Awareness of Hypertension Among Patients With Hypertension in Central Poland (2014) (8)
Left atrial and left atrial appendage systolic function in patients with post-myocardial distal blocks (2010) (8)
Which patients at risk of cardiovascular disease might benefit the most from inclisiran? Polish experts’ opinion. The compromise between EBM and possibilities in healthcare (2022) (8)
ORIGINAL PAPER Dynamics of changes of the BNP concentration in patients with stable angina pectoris qualified for PTCA. Dependence on the selected morphological and haemodynamic parameters (2006) (8)
Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF). (2019) (8)
A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults. (2022) (8)
Dysfunctional high-density lipoprotein: not only quantity but first of all quality? (2015) (8)
Low output syndrome following aortic valve replacement. Predictors and prognosis (2007) (8)
Papaverine solution improves preservation of saphenous vein grafts used during cardiac surgery (2008) (8)
Established and potential echocardiographic markers of embolism and their therapeutic implications in patients with ischemic stroke. (2018) (8)
Treatment adherence and effect of concurrent statin intensity on the efficacy and safety of alirocumab in a real-life setting: results from ODYSSEY APPRISE (2021) (8)
Pathophysiological mechanisms of statin‐associated myopathies: possible role of the ubiquitin‐proteasome system (2020) (8)
Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials (2018) (8)
The potential role of inflammation in cryptogenic stroke. (2019) (8)
Do we know more about hypertension in Poland after the May Measurement Month 2017?—Europe (2019) (8)
Can impedance cardiography be routinely applied in patients with sepsis and severe sepsis (2006) (8)
Observations on Degenerative Changes Within the Optic Nerve in Patients With Primary Open Glaucoma and Arterial Hypertension: 6‐Month Follow‐Up (2012) (8)
Investigating dysfunctional-hdl in selected groups of patients at high risk of cardiovascular events (DYS-HDL study) - Protocol and organization (2014) (7)
Associations Among PCSK9 Levels, Atherosclerosis-Derived Extracellular Vesicles, and Their miRNA Content in Adults With Obesity (2022) (7)
Incretins and microRNAs: interactions and physiological relevance. (2020) (7)
Effect of Dietary Insulinemia on All-Cause and Cause-Specific Mortality: Results From a Cohort Study (2019) (7)
Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019 (2022) (7)
Novel anti-obesity drugs and plasma lipids (2014) (7)
Regulation of cardiac stem cells by microRNAs: State-of-the-art. (2019) (7)
Impact of fibrates on circulating cystatin C levels: a systematic review and meta-analysis of clinical trials (2018) (7)
A higher ratio of refined grain to whole grain is associated with a greater likelihood of chronic kidney disease: a population-based study (2018) (7)
CRISPR Gene Editing in Lipid Disorders and Atherosclerosis: Mechanisms and Opportunities (2021) (7)
Genetic testing in familial hypercholesterolaemia: What does it add? (2020) (7)
Lipid profile and left ventricular geometry pattern in obese children (2020) (7)
Α higher ratio of serum uric acid to serum creatinine could predict the risk of total and cause specific mortality- insight from a US national survey. (2019) (7)
Statin therapy in chronic viral hepatitis: a systematic review and meta-analysis of nine studies with 195,602 participants (2021) (7)
The Effects of Glucagon-Like Peptide-1 Receptor Agonists and Dipeptydilpeptidase-4 Inhibitors on Blood Pressure and Cardiovascular Complications in Diabetes (2021) (7)
Association of Serum PCSK9 Levels with Antibiotic Resistance and Severity of Disease in Patients with Bacterial Infections Admitted to Intensive Care Units (2019) (7)
Left ventricular dysfunction and NT-proBNP levels in patients with one-vessel disease after first ST-elevation myocardial infarction treated with primary coronary angioplasty. (2009) (7)
Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials. (2022) (7)
Where are the Recommendations on Healthy Lifestyle and Cardiovascular Disease Prevention for Pregnant Women? (2020) (7)
Letter on 'sodium-dependent modulation of systemic and urinary renalase expression and activity in the rat remnant kidney'. (2013) (6)
Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: Analysis of pooled patient-level data from phase 3 clinical trials (2020) (6)
Metabolic syndrome – a new definition and management guidelines (2022) (6)
Harnessing polyphenol power by targeting eNOS for vascular diseases (2021) (6)
Natural products for targeted therapy in precision medicine. (2018) (6)
A systematic review and meta-analysis of clinical trials investigating the effects of flaxseed supplementation on plasma C-reactive protein concentrations (2018) (6)
Effect of Pycnogenol on Blood Pressure: Findings From a PRISMA Compliant Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled, Clinical Studies (2019) (6)
Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022) (2022) (6)
Nutraceuticals for the Control of Dyslipidaemias in Clinical Practice (2021) (6)
[Aortic valve replacement in patients with heart failure]. (2006) (6)
More Good News on Statins and COVID-19 (2020) (6)
Comparison of LDL-C calculation by friedewald and martin/hopkins methods in 12,243 adults from the United States of America (2020) (6)
Rationale for Effective Prophylaxis Against COVID‐19 Through Simultaneous Blockade of Both Endosomal and Non‐Endosomal SARS‐CoV‐2 Entry into Host Cell (2021) (6)
Pharmacological management of malignant hypertension (2020) (6)
Remote Monitoring of Cardiac Implantable Electronic Devices in Patients Undergoing Hybrid Comprehensive Telerehabilitation in Comparison to the Usual Care. Subanalysis from Telerehabilitation in Heart Failure Patients (TELEREH-HF) Randomised Clinical Trial (2020) (6)
Protective Effects of Curcumin on Endothelium: An Updated Review. (2021) (6)
BNP concentration in patients with mitral stenosis. Dependence on selected morphological parameters (2006) (6)
Obesity and postoperative atrial fibrillation. Is there no connection? Comment on: Wanahita et al. "atrial fibrillation and obesity--results of a meta-analysis". (2008) (6)
Contemporary Management of Dyslipidemia (2022) (6)
A Greater Flavonoid Intake Is Associated with Lower Total and Cause-Specific Mortality: A Meta-Analysis of Cohort Studies (2020) (6)
The behaviour of bone mineral density and bone metabolism index in young and menopausal women with the consideration of body mass index. (2010) (6)
Risk Assessment and Clinical Management of Children and Adolescents with Heterozygous Familial Hypercholesterolaemia. A Position Paper of the Associations of Preventive Pediatrics of Serbia, Mighty Medic and International Lipid Expert Panel (2021) (6)
The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 (2022) (6)
Extreme cardiovascular risk-do we need a new risk category? (2021) (6)
Arterial Stiffness and Indices of Left Ventricular Diastolic Dysfunction in Patients with Embolic Stroke of Undetermined Etiology (2019) (6)
Potato consumption is associated with total and cause-specific mortality: a population-based cohort study and pooling of prospective studies with 98,569 participants (2020) (6)
The role of inflammation and the possibilities of inflammation reduction to prevent cardiovascular events (2022) (6)
Abstract T MP99: What Are the Blood Pressure Levels Associated With the Lowest Stroke Rates in the Elderly? Findings From the Reasons for Geographic and Racial Differences in Stroke (regards) Cohort Study (2014) (6)
Cardioprotective properties of leptin in patients with excessive body mass (2020) (6)
Associations between the lipid profile and the development of hypertension in young individuals – the preliminary study (2019) (5)
Mapping development and health effects of cooking with solid fuels in low-income and middle-income countries, 2000–18: a geospatial modelling study (2022) (5)
Impact of serum 25-hydroxyvitamin D 25(OH) on telomere attrition: A Mendelian Randomization study. (2019) (5)
Low-carbohydrate diet: forget restriction, replace with balance! (2019) (5)
Progression of diabetic retinopathy correlated with muscle perfusion disturbances of the lower limbs, with clinically important diagnostic recommendations (2010) (5)
Original paper NT-proBNP in patients after acute coronary syndrome with ST segment elevation subjected to early posthospitalization cardiologic rehabilitation (2006) (5)
The role of adiposity, diet and inflammation on the discordance between LDL-C and apolipoprotein B. (2021) (5)
The Use of Aspirin in Contemporary Primary Prevention of Atherosclerotic Cardiovascular Diseases Revisited: The Increasing Need and Call for a Personalized Therapeutic Approach (2020) (5)
Long-term safety and efficacy of bempedoic acid in patients at high risk of atherosclerotic cardiovascular disease: results from the CLEAR Harmony open-label extension study (2020) (5)
Original article Left ventricular dysfunction and NT-proBNP levels in patients with one-vessel disease after first ST-elevation myocardial infarction treated with primary coronary angioplasty (2009) (5)
Levosimendan – a calcium sensitising agent with potential anti‐arrhythmic properties (2010) (5)
[The role of infection in the pathogenesis of atherosclerosis]. (2004) (5)
Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized (2021) (5)
High sensitivity C-reactive protein, NT-proBNP and hemodynamic left ventricular function in acute coronary syndrome without ST segment elevation - a preliminary report. (2010) (5)
The concentration of uric acid in patients with metabolic syndrome and cardiovascular diseases (2009) (5)
Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning (2021) (5)
Curcumin - The Nutraceutical With Pleiotropic Effects? Which Cardiometabolic Subjects Might Benefit the Most? (2022) (5)
Association between rs2107595 HDAC9 gene polymorphism and advanced carotid atherosclerosis in the Slovenian cohort (2020) (5)
The detrimental impact of elevated Ferritin to Iron ratio on in-hospital prognosis of patients with COVID-19 (2022) (5)
Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia (2022) (5)
Anticoagulant prevention in patients with atrial fibrillation: alternatives to vitamin K antagonists. (2013) (5)
NT-proBNP levels correlate with organ failure in septic patients: a preliminary report. (2006) (5)
PCSK9 genetic variants, life-long lowering of LDL-cholesterol and cognition: a large-scale Mendelian randomization study (2018) (5)
Editorial: Natural Products as the Integral Part of the Therapy? (2017) (5)
Serum anti-inflammatory and inflammatory markers have no causal impact on telomere length: a Mendelian randomization study (2021) (5)
ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design. (2018) (5)
Percutaneous Coronary Interventions Affect Concentrations of Interleukin 6 and Its Soluble Receptors in Coronary Sinus Blood in Patients With Stable Angina (2009) (5)
Modern prevalence of the Fredrickson-Levy-Lees dyslipidemias: findings from the Very Large Database of Lipids and National Health and Nutrition Examination Survey (2019) (5)
P5306The comparison of the lipid profile in the population of Poland between 2004, 2006 and 2015 based on the results of the LIPIDOGRAM cohort studies (2017) (4)
The Differences in the Prevalence of Cardiovascular Disease, Its Risk Factors, and Achievement of Therapeutic Goals among Urban and Rural Primary Care Patients in Poland: Results from the LIPIDOGRAM 2015 Study (2021) (4)
Extracorporeal dialysis: techniques and adequacy - A (2013) (4)
Relevance of 123I-BMIPP delayed scintigraphic imaging for patients with angina pectoris – a pilot study (2011) (4)
Are Markers of Cardiac Dysfunction Useful in the Assessment of Cardiovascular Risk in Dialysis Patients? (2017) (4)
Pre-CKD- do we need another hero? (2014) (4)
Editorial: MicroRNA-33 Inhibition: A Potential Adjunct to Statin Therapy? (2016) (4)
4120Anti-tumor activity of a nanoliposomal anti-PCSK9 vaccine in BALB/c mice bearing 4T1 breast cancer (2019) (4)
Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE‐AF) randomized trial (2020) (4)
Effects of tibolone on fibrinogen and antithrombin III: A systematic review and meta‐analysis of controlled trials (2017) (4)
Dyslipidemia Management in Patients with Coronary Artery Disease. Data from the POLASPIRE Survey (2021) (4)
From Editor-in-Chief Impact Factor 2009 – the main aim of Archives of Medical Science (2007) (4)
Longer sleep duration may negatively affect renal function (2020) (4)
Clinical Features of Familial Hypercholesterolemia in Children and Adults in EAS-FHSC Regional Center for Rare Diseases in Poland (2021) (4)
Statins and Fibrates: Should They Be Recommended? (2015) (4)
Cost-effectiveness of telerehabilitation in patients with heart failure in Poland: an analysis based on the results of the Telerehabilitation in Heart Failure Patients (TELEREH-HF) randomized clinical trial. (2021) (4)
May Measurement Month 2018: an analysis of blood pressure screening campaign results from Poland (2020) (4)
Omega-6 fatty acids and the risk of cardiovascular disease: insights from a systematic review and meta-analysis of randomized controlled trials and a Mendelian randomization study (2021) (4)
Predictors of Long COVID in Patients without Comorbidities: Data from the Polish Long-COVID Cardiovascular (PoLoCOV-CVD) Study (2022) (4)
LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN SUBJECTS WITH METABOLIC SYNDROME (2008) (4)
Influence of exercise training on T-wave alternans assessed during exercise test in heart failure patients. (2014) (4)
Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A Position Paper of the International Lipid Expert Panel. (2022) (4)
Letter by Banach et al regarding article, "postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting". (2008) (4)
Impedance cardiography in haemodynamic monitoring of septic patients: a prospective study (2007) (4)
Epigenetics in atherosclerosis: key features and therapeutic implications (2020) (4)
The Yin and Yang of High-density Lipoprotein and Atherosclerotic Cardiovascular Disease: Focusing on Functionality and Cholesterol Efflux to Reframe the HDL Hypothesis. (2021) (4)
Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988) (2022) (4)
Prediabetes, Prehypertension- do we Need PRE-CKD? (2013) (4)
A close‐up view of dynamic biomarkers in the setting of COVID‐19: Striking focus on cardiovascular system (2021) (4)
Glucose-6-phosphate dehydrogenase deficiency and SARS-CoV-2 mortality: Is there a link and what should we do? (2020) (4)
Investigation of the Effect of Curcumin on Protein Targets in NAFLD Using Bioinformatic Analysis (2022) (4)
Attenuation of isoprenaline-induced myocardial infarction by Rheum turkestanicum. (2022) (4)
Polish Lipid Association--a strong response to the problem of lipid disorders in Poland and Central and Eastern Europe. (2012) (4)
Patients with prehypertension - do we have enough evidence to treat them? (2014) (4)
Significance of 99mTc-Sestamibi myocardial scintigraphy after percutaneous coronary intervention in patients with acute myocardial infarction (2011) (4)
The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact (2022) (4)
Bempedoic Acid: for Whom and When (2022) (4)
P6194Therapeutic effect of nanoliposomal anti-PCSK9 vaccine on hypercholesterolemia and atherosclerosis in C57BL/6 mice (2019) (4)
[The influence of L-arginine on secretion of nitric oxide and haemodynamic function of isolated rat's heart subjected to cold cardioplegic ischemia and reperfusion]. (2004) (3)
Dofetilide for the prevention of postoperative atrial fibrillation after coronary surgery: is it a useful routine prophylaxis? (2008) (3)
Aortic stiffness in diabetes mellitus – association with glutamine and heat shock protein 70 expression: a pilot study based on an experimental rodent model (2009) (3)
Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases (2017) (3)
Clinical research Decreased kidney function as a risk factor for cardiovascular events in subjects with metabolic syndrome – a pilot study (2009) (3)
P673Moderate anti-tumor effect of the nanoliposomal anti-PCSK9 vaccine in BALB/c mice bearing colorectal cancer (2019) (3)
Renal Denervation for Uncontrolled and Resistant Hypertension: Systematic Review and Network Meta-Analysis of Randomized Trials (2021) (3)
An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial (2021) (3)
De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy? (2022) (3)
Coffee or tea: Anti-inflammatory properties in the context of atherosclerotic cardiovascular disease prevention. (2022) (3)
Effects of hybrid comprehensive telerehabilitation on cardiopulmonary capacity in heart failure patients depending on diabetes mellitus: subanalysis of the TELEREH-HF randomized clinical trial (2021) (3)
How can we decrease mortality in surgery units (2008) (3)
Oxidative stress and atherosclerosis in chronic kidney disease (2009) (3)
Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score (2018) (3)
P704Nanoliposomal anti-PCSK9 vaccine ameliorates glucose intolerance and insulin resistance in diabetic rats (2019) (3)
Editorial: current research, knowledge and controversies on high density lipoprotein. (2014) (3)
Safety and efficacy of drug eluting stents vs bare metal stents in patients with atrial fibrillation: A systematic review and meta-analysis. (2020) (3)
P5304Prevalence of familial hypercholesterolemia in Poland in the LIPIDOGRAM2004 and 2006 population-based surveys (2017) (3)
Biochemical and cardiovascular predictors of PIMS-TS risk in children after COVID-19 recovery: preliminary results of the LATE-COVID-Kids Study (2022) (3)
Comparative effect of nutraceuticals on lipid profile: a protocol for systematic review and network meta-analysis (2020) (3)
Evaluation of medical and psychological parameters of quality of life in supraventricular tachyarrhythmia children. A comparison with healthy children (2016) (3)
Predictor markers of postoperative atrial fibrillation (2007) (3)
The cardioprotective effect of trimetazidine in patients undergoing surgical revascularization (2005) (3)
The outcomes of hypertension treatment depending on gender in patients over 40 years of age (2020) (3)
Effect of the Renin-Angiotensin System Inhibitors on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials. (2022) (3)
Omega-6 fatty acids and risk of cardiovascular disease: insight from systematic review and meta-analysis of randomized controlled trials and a mendelian randomization study (2020) (3)
Quality of life in heart failure patients undergoing hybrid comprehensive telerehabilitation versus usual care results of TELEREH-HF randomized clinical trial (2020) (3)
Angiotensin converting-enzyme inhibitors and candesartan have no effects on atrial fibrillation after cardiac surgery: comment on: Mehmet Ozaydin et al. "Effect of renin-angiotensin aldosterone system blockers on postoperative atrial fibrillation". (2010) (3)
THE EFFECT OF QUERCETIN ON BLOOD PRESSURE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2016) (3)
Protective Effects of Curcumin Phytosomes Against High-Fat Diet-Induced Atherosclerosis. (2021) (3)
Combination Therapy In Dyslipidemia (2015) (3)
Author Correction: Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials (2020) (3)
Hypertension and Prevention of Diastolic Heart Failure in the Aging Population (2014) (3)
Association between statin use and plasma d-dimer levels – A systematic review and meta-analysis of randomized controlled trials (2015) (3)
“Apple does not fall far from the tree” – subclinical atherosclerosis in children with familial hypercholesterolemia (2020) (3)
Impact of PCSK9 Immunization on Glycemic Indices in Diabetic Rats (2021) (3)
Post-exercise Hypotension in the Elderly (2019) (3)
Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paper (2022) (3)
Prophylactic aspirin for preventing pre-eclampsia and its complications: An overview of meta-analyses. (2020) (3)
[Endothelial dysfunction in hypertension. The role of natriuretic peptides and endothelin]. (2005) (3)
CASE REPORT A 42-year-old patient with alcoholic cardiomyopathy (2005) (3)
Impact of anemia treatment with methoxy polyethylene glycol-epoetin beta on polymorphonuclear cells apoptosis in predialysis patients with chronic kidney disease. (2015) (3)
Original paper Impedance cardiography in haemodynamic monitoring of septic patients: a prospective study (2007) (3)
The lipid disorders therapy in overweight patients (2005) (3)
LOW HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND INCIDENT CORONARY HEART DISEASE AMONG WHITES IN THE REASONS FOR GEOGRAPHIC AND RACIAL DIFFERENCES IN STROKE (REGARDS) STUDY (2016) (3)
P5330Evaluating lipid-lowering and anti-atherogenic effect of injectable curcumin in a rabbit model of atherosclerosis (2019) (3)
The cardiologists' dream may come true - vascular therapy (2005) (3)
Individualized therapy in statin intolerance: the key to success. (2022) (3)
Atrial fibrillation in dialysis patients: is there a place for non-vitamin K antagonist oral anticoagulants? (2018) (3)
AMS congress report Heart Failure and Europace 2005 (2005) (3)
[Management of familial heterozygous hypercholesterolaemia. Position paper of the Polish Lipid Expert Forum]. (2013) (3)
The spoils of war and the long-term spoiling of health conditions of entire nations (2022) (3)
Molecularly targeted nanoparticles: an emerging tool for evaluation of expression of the receptor for advanced glycation end products in a murine model of peripheral artery disease (2021) (3)
Cellular senescence, telomeres, and cardiovascular risk in familial hypercholesterolaemia. (2020) (3)
Editorial (Thematic Issue: The Changing Face of Metabolic Syndrome and its Components in the Light of Current Knowledge) (2014) (2)
Vitamin D and SAMS (2020) (2)
The Relationship of Dehydration and Body Mass Index With the Occurrence of Atrial Fibrillation in Heart Failure Patients (2021) (2)
Associations Between Very Low Concentrations of LDL-Cholesterol, hs-CRP and Health Outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) Study (2017) (2)
Effect of Metformin on Plasma Fibrinogen Concentrations: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. (2018) (2)
Editorial (Thematic Issue: Current Research, Knowledge and Controversies on High Density Lipoprotein) (2014) (2)
Discordance between LDL-C and Apolipoprotein B Levels and Its Association with Renal Dysfunction: Insights from a Population-Based Study (2022) (2)
Statin intolerance: time to stop letting it get in the way of treating patients (2022) (2)
Lipids profile and efficacy of treatment of dyslipidemia in primary care in Poland. Results of lipidogram 5 years study (2004-2010). (2017) (2)
Associations between cardiovascular disease, cancer and very low HDL cholesterol in the REasons for Geographical And Racial Differences in Stroke (REGARDS) study. (2017) (2)
[Heart condition before and after surgical treatment of atrial septal defect type II in adults]. (2005) (2)
Corrigendum to "Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the cardiovascular health study" [Int. J. Cardiol. 235 (2017) 11-16]. (2017) (2)
Negatively-charged liposome nanoparticles can prevent dyslipidemia and atherosclerosis progression in the rabbit model. (2021) (2)
The effect of statins on the prevalence and mortality of influenza virus infection: a systematic review and meta-analysis (2022) (2)
Coffee and caffeine consumption and overall mortality. Pleasure with restrictions - where do we really stand in 2022? (2022) (2)
Identification of New Copy Number Variation and the Evaluation of a CNV Detection Tool for NGS Panel Data in Polish Familial Hypercholesterolemia Patients (2022) (2)
Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study (2021) (2)
Impact of bariatric surgery on circulating PCSK9 levels as a marker of cardiovascular disease risk: a meta-analysis (2022) (2)
Are Polymorphisms within Endothelial Nitric Oxide Synthase Good Predictors of Coronary Artery Disease? (2010) (2)
Assessment of ECG during hybrid comprehensive telerehabilitation in heart failure patients—Subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) randomized clinical trial (2021) (2)
Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018 (2022) (2)
The International Lipid Expert Panel (ILEP)-the role of 'optimal' collaboration in the effective diagnosis and treatment of lipid disorders. (2021) (2)
The role of PCSK9 in NAFLD/NASH and therapeutic implications of PCSK9 inhibition (2022) (2)
D-003 (Saccharum officinarum): The forgotten lipid-lowering agent. (2016) (2)
Adverse impact of egg consumption on fatty liver is partially explained by cardiometabolic risk factors: A population-based study. (2020) (2)
Bempedoic Acid and Glycemic Control: A Pooled Analysis of 4 Phase 3 Clinical Trials (2020) (2)
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI (2022) (2)
Abstract 13360: A Network Meta-Analysis on the Comparative Efficacy of Nutraceuticals on Lipid Profile (2019) (2)
Is COVID-19 another case of the obesity paradox? Results from an international ecological study on behalf of the REPROGRAM Consortium Obesity study group (2021) (2)
Role of statins in the treatment of heart disease. Heart failure (2005) (2)
Stroke as a result of cardioembolism — characteristic features in the context of diagnostic methods and secondary prevention (2018) (2)
Use of Combination Statin and Bile Acid Sequestrant Therapy to Treat Dyslipidemia (2015) (2)
Effect of L-arginine on oxygen consumption and haemodynamic function of rat's heart exposed to cold cardioplegic ischaemia and reperfusion. (2002) (2)
Hypertensive urgencies during the first wave of the COVID-19 pandemic in a tertiary hospital setting: a U-shaped alarming curve (2021) (2)
Effect of bempedoic acid on uric acid and gout in 3621 patients with hypercholesterolemia: pooled analyses from phase 3 trials (2020) (2)
85 Risk factors of atrial fibrillation after coronary artery bypass grafting (2005) (2)
Coenzyme Q10 Reduces Infarct Size in Animal Models of Myocardial Ischemia-Reperfusion Injury: A Meta-Analysis and Summary of Underlying Mechanisms (2022) (2)
Tibolone can decrease lipoprotein(a) concentrations in postmenopausal women: a systematic review and meta-analysis of controlled trials (2015) (2)
The cholesterol paradox in atrial fibrillation: results from the LIPIDOGRAM 2015 study (2020) (2)
Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study (2021) (2)
New trends in the pharmacological intervention of PPARs in obesity: Role of natural and synthetic compounds_. (2020) (2)
Role of confirmed and potential predictors of an unfavorable outcome in heart failure in everyday clinical practice (2021) (2)
The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study (2022) (2)
eComment: The anastomosis between aorta and extension conduit of the pulmonary artery. (2007) (2)
The association between coffee and caffeine consumption and renal function: insight from individual-level data, Mendelian randomization, and meta-analysis (2021) (2)
Arterial hypertension in patients with coronary artery disease treated with coronary artery bypass surgery (2009) (2)
FACTORS THAT INFLUENCE BEMPEDOIC ACID-MEDIATED REDUCTIONS IN HIGH-SENSITIVITY C-REACTIVE PROTEIN: ANALYSIS OF POOLED PATIENT-LEVEL DATA FROM PHASE 3 CLINICAL TRIALS (2020) (2)
Biological and practical considerations regarding circadian rhythm and mental health relationships among nurses working night shifts: a narrative review and recommendations. (2022) (2)
Phytochemicals: A potential therapeutic intervention for the prevention and treatment of cachexia. (2022) (2)
SLEEP DURATION MAY NOT HAVE ANY EFFECT ON THE RISK OF STROKE: INSIGHTS FROM MENDELIAN RANDOMIZATION AND PROSPECTIVE COHORT STUDIES (2020) (2)
Can the effects of gender, menopause and ageing on lipid levels be differentiated? (2016) (2)
May Measurement Month 2019: an analysis of blood pressure screening results from Poland (2021) (2)
P5409Low-carbohydrate diets and all-cause and cause-specific mortality: a population-based cohort study and pooling prospective studies (2018) (2)
Can We Use mTOR Inhibitors for COVID-19 Therapy? (2021) (2)
Dyslipidemia Management in Pregnancy: Why Is It not Covered in the Guidelines? (2022) (2)
Identification of Potent Small-Molecule PCSK9 Inhibitors Based on Quantitative Structure-Activity Relationship, Pharmacophore Modeling, and Molecular Docking Procedure. (2023) (1)
Compositional and functional properties of high-density lipoproteins in relation to coronary in-stent restenosis (2021) (1)
Strength-endurance training may promote pro-atherogenic changes in lipoprotein profile of adolescent rowers (2015) (1)
Preclinical toxicity assessment of a peptide-based antiPCSK9 vaccine in healthy mice. (2022) (1)
The immunogenic potential of PCSK9 peptide vaccine in mice. (2022) (1)
Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study (2016) (1)
P5313The association between coffee and caffeine consumption and renal function: insight from individual-level data, Mendelian randomization, and meta-analysis (2019) (1)
Killing the Culprit: Pharmacological Solutions to Get Rid of Cholesterol Crystals. (2022) (1)
Effect of Serum Lipid Profile on the Risk of Breast Cancer: Systematic Review and Meta-Analysis of 1,628,871 Women (2022) (1)
[Blood serum and neutrophil amino acid concentrations during hemodialysis]. (2005) (1)
Treating mild hypertension in young adults: is pharmacotherapy necessary? (2020) (1)
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP). (2023) (1)
Heart Failure Risk Predictions and Prognostic Factors in Adults With Congenital Heart Diseases (2022) (1)
CETP inhibition in the REVEAL trial: could we aim higher? (2020) (1)
Invited review The role of trimetazidine in patients subjected to surgical revascularization (2008) (1)
Case report Toxic epidermal necrolysis (Lyell’s syndrome): case report and review of the literature (2009) (1)
Associations between Periodontitis, COVID-19, and Cardiometabolic Complications: Molecular Mechanisms and Clinical Evidence (2022) (1)
Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update (2023) (1)
BEMPEDOIC ACID EFFICACY AND SAFETY IN HIGH CVD RISK PATIENTS TREATED WITH OR WITHOUT EZETIMIBE: POOLED ANALYSIS OF 4 PHASE 3 CLINICAL TRIALS (2020) (1)
P2549The cardiovascular predictors of clinical outcomes in patients after ischemic stroke of undetermined etiology (2019) (1)
Drug Evaluation: The Combination of Fenofibrate and Simvastatin for the Treatment of Dyslipidemia: When and for Whom? (2015) (1)
Abstract 16850: Effect of Alirocumab in Patients With Diabetic Dyslipidemia and Chronic Kidney Disease (2016) (1)
Advanced cardiometabolic & inflammatory markers for prediction of cardiovascular disease and cancer (2020) (1)
Antiarrhythmic effect of 9-week hybrid comprehensive telerehabilitation and its influence on cardiovascular mortality in long-term follow-up – subanalysis of the TELEREHabilitation in Heart Failure Patients randomized clinical trial (2021) (1)
Ventricular Assist Device – How to Obtain Optimal Benefits? (2011) (1)
Left Ventricular Diastolic Dysfunction as Predictor of Unfavorable Prognosis After ESUS (2021) (1)
Cost-effectiveness of telerehabilitation in patients with heart failure in Poland: an analysis based on the results of Telerehabilitation in the Heart Failure Patients (TELEREH-HF) randomized clinical trial. (2021) (1)
Leptin, cardiovascular diseases and type 2 diabetes mellitus (2018) (1)
Are statins beneficial in patients with vasospastic angina? A meta-analysis of observational studies. (2022) (1)
P5368The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in Poland: results of the TERCET registry (2019) (1)
Markers of increased cardiovascular risk in elderly patients with chronic kidney disease: A preliminary study (2015) (1)
[Leveling down to worse - parametrical evaluation of scientific journals by Polish Ministry of Science and Higher Education, that is why high quality and recognised medical journals, including Polish Heart Journal, cannot have 10 points?]. (2009) (1)
92 Low BMI as an independent risk factor of death in patients with severe heart failure subjected to aortic valve replacement (2007) (1)
Sex-dependent differences in obesity indices and inflammatory markers in non-diabetic obese patients (2015) (1)
COMPARISON OF CLINICAL OUTCOMES BETWEEN BIORESORBABLE VASCULAR STENTS VERSUS CONVENTIONAL DRUG-ELUTING AND METALLIC STENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS (2016) (1)
Low levels of low-density lipoprotein cholesterol, intracerebral haemorrhage, and other safety issues: is there still a matter of debate? (2022) (1)
Abstract T P136: Potential Contributors to the Declining Impact of Stroke Risk Factors with Age: Implications for Stroke Epidemiology in the Elderly (2014) (1)
Statins and atrial fibrillation - mini - review on recent evidence (2017) (1)
Editorial: the changing face of metabolic syndrome and its components in the light of current knowledge. (2014) (1)
[Isolated ventricular noncompaction]. (2006) (1)
Markers of increased cardiovascular risk in patients with chronic kidney disease (2014) (1)
Effect of L-arginine on overhydration and ultrastructure preservation of rat's heart exposed to cold cardioplegic ischaemia. (2003) (1)
Primary prevention. The cornerstone to reduce the burden of cardiovascular disease. (2021) (1)
P1181Clinical factors related to successful or unsuccessful cardioversion in the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial (2018) (1)
Prevalence of anti-nuclear autoantibodies (ANA) in the general Polish population - analysis of the influence of sex and age on the variability of ANA. (2021) (1)
Effect of Curcumin on Attenuation of Liver Cirrhosis via Genes/Proteins and Pathways: A System Pharmacology Study (2022) (1)
Response letter: Management of statin‐induced myopathies: Much demands and still (almost) empty hands! (2017) (1)
Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol: Analysis of pooled data from four phase 3 clinical trials. (2023) (1)
From meta‐analysis to Cochrane reviews (2018) (1)
A 42-year-old patient with alcoholic cardiomiopathy (2005) (1)
2154Apolipoprotein B/apolipoprotein A-I ratio is comparable with C-reactive protein in predicting cancer mortality: results from two multi-ethnic US populations (2019) (1)
185-OR: Efficacy and Safety of Bempedoic Acid in Patients with Diabetes, Prediabetes, and Normoglycemia: Analysis of Pooled Patient-Level Data from Four Phase 3 Clinical Trials (2020) (1)
P3400Definition of extremely high cardiovascular risk in patients after acute myocardial infarction - Data from the TERCET Registry (2019) (1)
Incidence of familial hypercholesterolemia in patients from the tercet registry (2018) (1)
P6389Arterial stiffness and indices of diastolic heart failure as predictors of ischemic strokes of undetermined etiology (2018) (1)
The overlapping burden of the three leading causes of disability and death in sub-Saharan African children (2022) (1)
DZIELIMY SIĘ DOŚWIADCZENIEM Cardiac tamponade with acute hypovolaemic shock induced by a right ventricular lesion during implan-tation of a PHILOS SR cardiostimulator and a SELOX ST 60 ventricular electrode – a case report (2010) (1)
Vitamin D deficiency and metabolic syndrome: any link with statin intolerance and adipokines dysregulation? (2016) (1)
Perspective application of metabolic treatment (trimetazidine) in patients with left ventricle dysfunction (2006) (1)
Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia (2022) (1)
Relationship Between Anti-DFS70 Autoantibodies and Oxidative Stress (2022) (1)
2021 PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on the diagnosis and therapy of lipid disorders in Poland (2021) (1)
Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs – The CAPISCO International Expert Panel (2022) (1)
Risk factor modification after ACS Non-pharmacological management after acute coronary syndromes (2010) (1)
Abstract 18649: Comparative Impact of Isolated Systolic Hypertension vs Systolic-Diastolic Hypertension on Incident Heart Failure and All-Cause Mortality in Community-Dwelling Older Adults (2014) (1)
[Risk stratification of patients before heart surgery. One scale isn't enough...]. (2010) (1)
Abstract WP214: Differential Impact of Stroke Risk Factors Across the Age Spectrum: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study (2019) (1)
Arteriovenous Fistula Leading to Severe Tortuosity and Aneurysm Formation (2009) (1)
[Prodiabetic effect of statins--do we know the mechanisms of this phenomenon?]. (2012) (1)
Free-floating thrombus in the inferior caval vein and the right atrium (2007) (1)
Low- and High-Density Lipoprotein Subclasses in Subjects with Non-Alcoholic Fatty Liver Disease (2016) (1)
2022: the year in cardiovascular disease – the year of upfront lipid lowering combination therapy (2022) (1)
[Evaluation of surgical treatment of mitral valve defect in patients with chronic renal failure]. (2006) (1)
Abstract 19285: Vitamin D Influences Biomarkers of Oxidative Stress and Serum High Sensitivity C-Reactive Protein Concentrations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2016) (1)
Definition and Characteristics of Hypertension Associated with Chronic Kidney Disease: Epidemiological Data (2017) (1)
P6195Nanoliposomal anti-PCSK9 vaccine induces long-term and safe protection against atherosclerosis in C57BL/6 mouse (2019) (1)
Antiarrhythmic effect of 9-week hybrid cardiac telerehabilitation - subanalysis of the TELEREHabilitation in Heart Failure patients - TELEREH-HF randomized clinical trial (2021) (1)
Use of multidimensional item response theory methods for dementia prevalence prediction: an example using the Health and Retirement Survey and the Aging, Demographics, and Memory Study (2021) (1)
RELATIONSHIP BETWEEN LOW-DENSITY LIPOPROTEIN CHOLESTEROL, LIPID LOWERING AGENTS AND THE RISK OF STROKE: A META-ANALYSIS OF OBSERVATIONAL STUDIES AND RANDOMIZED CONTROLLED TRIALS (2020) (1)
P253 Patient after correction of Taussig-Bing anomaly with severe neoaortic regurgitation and after sudden cardiac arrest (2020) (1)
Phase 3 Evaluation of Bempedoic Acid Added to Ezetimibe in Patients with Elevated LDL-cholesterol Receiving No Greater Than Low Dose Statins: CLEAR Tranquility (2018) (1)
WITHDRAWN: Α higher ratio of serum uric acid to serum creatinine could predict the risk of total and cause specific mortality - Insight from a US national survey. (2019) (1)
EFFICACY AND SAFETY OF ALIROCUMAB IN A REAL-LIFE SETTING IN PATIENTS WITH OR WITHOUT FAMILIAL HYPERCHOLESTEROLEMIA: THE ODYSSEY APPRISE STUDY (2020) (1)
IMPACT OF BODY MASS INDEX AND OBESITY ON CLINICAL OUTCOMES IN THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) RANDOMIZED TRIAL (2018) (1)
Diminishing benefits of urban living for children and adolescents’ growth and development (2023) (0)
Beta-blockers in the treatment of heart failure CIBIS III Trial (2005) (0)
The Progress and Research Trends of Statin Medications: Advanced Epidemiological and Bibliometrical Assessment. (2023) (0)
Glucose-Dependent Insulinotropic Polypeptide Plasma Level Influences the Effect of n-3 PUFA Supplementation (2022) (0)
Case report Free-floating thrombus in the inferior caval vein and the right atrium (2008) (0)
A systematic review and meta-analysis comparing the effects of statins and fibrates on plasma lipoprotein(a) levels (2016) (0)
Genetically Higher Level of Mannose Has No Impact on Cardiometabolic Risk Factors: Insight from Mendelian Randomization (2021) (0)
The effect of PCSK9 immunization on the hepatic level of microRNAs associated with the PCSK9/LDLR pathway (2022) (0)
Issue Information‐ToC (2019) (0)
Edinburgh Research Explorer Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease (2018) (0)
P3-49: B-type natriuretic peptide as a new predictor of atrial fibrillation in patients undergoing isolated coronary bypass surgery (2006) (0)
Cardiovascular outcomes in community-dwelling older adults with chronic obstructive pulmonary disease (2013) (0)
Metabolic syndrome is associated with similar long-term prognosis in non-obese and obese patients. An analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 cohort studies. (2023) (0)
Current guidelines (2005) of diagnostics and management in infective endocarditis (2005) (0)
Lack of efficacy of resveratrol on cardiovascular parameters? Results from a systematic review and meta-analysis of randomized controlled trials (2015) (0)
The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy – 5-year follow-up (2013) (0)
748 Early and long‐term results of mechanical aortic valve replacement in patients with stenosis or aortic valve regurgitation. The influence on improvement of haemodynamic parameters of heart (2005) (0)
2458The role of statins in patients with heart failure with preserved, mid-range and reduced ejection fraction; a meta-analysis and systematic review (2018) (0)
P1311 A rare case of asymptomatic cyst in interatrial septum longterm observation (2020) (0)
A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS EVALUATING RENAL DENERVATION FOR UNCONTROLLED AND RESISTANT HYPERTENSION (2020) (0)
Review for "Greater variability in lipid measurements associated with cardiovascular disease and mortality: 10‐year diabetes cohort study" (2020) (0)
The influence of curcumin additives on the viability of probiotic bacteria, antibacterial activity against pathogenic microorganisms, and quality indicators of low-fat yogurt (2023) (0)
Health Care Cost In Patients Undergoing Electrical Cardioversion: An analysis from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ensure-af) study (2017) (0)
Impact of vitamin D receptor polymorphisms in selected metabolic disorders. (2023) (0)
Conclusions and Take Home Message (2015) (0)
Dietary patterns, plasma vitamins and Trans fatty acids are associated with peripheral artery disease (2017) (0)
Open Up your Science in EHJ Open (2021) (0)
Lower Discharge Systolic Blood Pressure (SBP) and Poor Outcomes Among Hospitalized Patients With Heart Failure and Reduced Ejection Fraction (HFrEF) and Stable Admission-to Discharge SBP (2017) (0)
Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors - analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studies. (2021) (0)
Relationship between Low-Density Lipoprotein Cholesterol, Lipid Lowering Agents and the Risk of Stroke: A meta-analysis of Observational studies (n=355,591) and Randomized Controlled Trials (2022) (0)
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension^Chinese Hypertension League Stroke in Hypertension OptimalTreatment randomized trial (2014) (0)
From Editor-in-Chief New face of Archives of Medical Science (2006) (0)
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection (2021) (0)
Editorial: Telemedicine during and beyond COVID-19, volume II (2022) (0)
DECREASED KIDNEY FUNCTION AS A RISK FACTOR FOR ATHEROSCLEROTIC CARDIOVASCULAR EVENTS IN SUBJECTS WITH METABOLIC SYNDROME AND HIGH CARDIOVASCULAR RISK (2008) (0)
Non-pharmacological management after acute coronary syndromes (2010) (0)
Evaluation of obesity in patients with metabolic syndrome (2007) (0)
I am attaching (i) Barco's Reply in Support of its Motion to Strike Portions of TPL's Third Amended Infringement Contentions, (ii) a declaration by Edward Runyan, and (iii) Exhibit R. (2012) (0)
Relationships between physical capacity and depression in heart failure patients undergoing hybrid comprehensive telerehabilitation vs usual care results of the TELEREH-HF randomized clinical trial (2021) (0)
Molecularly targeted nanoparticles: an emerging tool for evaluation of expression of the receptor for advanced glycation end products in a murine model of peripheral artery disease (2021) (0)
Editorial Complications of Diabetes (2015) (0)
Department of Error (2020) (0)
Extreme cardiovascular risk-do we need a new risk category? (2022) (0)
Which statin is best for the kidneys? (2022) (0)
Dietary food patterns and glucose/insulin homeostasis: a cross-sectional study involving 24,182 adult Americans (2017) (0)
Statins and sudden cardiac death - mini review on available data (2017) (0)
Retraction Note: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis (2023) (0)
The results of direct revascularization of heart in patients over 75 years old (1999) (0)
Consciousness disorders following cardiac surgery (2007) (0)
Statin therapy in hepatitis: a systematic review and meta-analysis of 9 studies with 195,602 participants (2021) (0)
Percutaneous Coronary Intervention Associated with a Higher Risk of Hypoxemia and COVID-19 Severity. (2023) (0)
Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials (2018) (0)
NT-proBNP – N-terminal brain natriuretic propeptide; PCT – procalcitonin; SIRS – systemic inflammatory response syndrome; SOFA score – sepsis-related organ failure assessment score Short communication N-TERMINAL BRAIN NATRIURETIC PROPEPTIDE LEVELS CORRELATE WITH PROCALCITONIN AND C-REACTIVE PROTEIN (2007) (0)
Synthesis, Chemical Characterization and Multiscale Biological Evaluation of a Dimeric-cRGD Peptide for Targeted Imaging of αVβ3 Integrin Activity (2017) (0)
Impact of ursodeoxycholic acid on circulating lipid concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials (2019) (0)
Cardioprotective effects of minocycline against doxorubicin-induced cardiotoxicity. (2022) (0)
Full Reviews The quest for equilibrium: exploring the thin red line between bleeding and ischaemic risks in the management of acute coronary syndromes in chronic kidney disease patients (2017) (0)
Subfractions/subpopulations of HDL cholesterol and dysfunctional HDL- A time for new biomarkers in lipid disorders patients? (2014) (0)
P6259Association of high-sensitivity C-reactive protein and metabolic syndrome prevalence in U.S. adults (2017) (0)
Statins – Do we really know all mechanisms of action of this group of drugs? (2011) (0)
Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis (2019) (0)
Abstract 11946: Effect of Evolocumab on Non-high-density Lipoprotein Cholesterol and Apolipoprotein B Levels: An Analysis of Double-blind and Open-label Extension Studies (2019) (0)
Abstract 18967: Analysis of Vitamin D Levels in Patients With and Without Statin-induced Myalgia - A Systematic Review and Meta-analysis of 7 Studies with 2416 Patients (2014) (0)
Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases (2016) (0)
Adherence to statin therapy: it seems we know everything, yet we do nothing (2022) (0)
Knowledge of Primary Care Patients Living in the Urban Areas about Risk Factors of Arterial Hypertension (2023) (0)
Erratum to: Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study (2016) (0)
Association between rs2107595 HDAC9 gene polymorphism and advanced carotid atherosclerosis in the Slovenian cohort (2020) (0)
P6268Association between familial hypercholesterolemia and telomere length in US adults (2018) (0)
Serum lipophilic antioxidants levels are associated with leucocyte telomere length among US adults (2018) (0)
Management of Statin Intolerance (2020) (0)
Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019 (2023) (0)
246 Can we prevent atrial fibrillation following surgical revascularization (2006) (0)
45Association of types of dietary fats and all-cause and cause-specific mortality: a prospective cohort study and meta-analysis of prospective studies with 1,148,117 participants (2019) (0)
Contents Vol. 116, 2010 (2010) (0)
Correction to: Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis (2020) (0)
Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia (2022) (0)
Hydration status, BMI and troponin as factors of an impaired exercise tolerance in women over 40 with arterial hypertension (2021) (0)
In vivo protein interaction between Escherichia coli β sliding clamp and other proteins (2000) (0)
Hypotensive Syndromes in Geriatric Patients (2020) (0)
Global spotlights PCSK9 vaccine: so near, yet so far! (2021) (0)
Actual state of knowledge to the point of epidemiology, diagnosis and management with cardiac syndrome X (2005) (0)
Evaluation of a dimeric-cRGD peptide for targeted PET-CT imaging of peripheral angiogenesis in diabetic mice (2018) (0)
Erratum to: Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study (2016) (0)
Dyslipidemia treatment and attainment of LDL-cholesterol treatment goals in patients participating in the Managed Care for Acute Myocardial Infarction Survivors program. (2023) (0)
Factors of persistent limited exercise tolerance in patients after COVID-19 with normal left ventricular ejection fraction (2022) (0)
1443Safety of red yeast rice supplementation: a systematic review and meta-analysis of randomized controlled trials (2019) (0)
Heart Failure Patients’ Adherence to Hybrid Comprehensive Telerehabilitation and Its Impact on Prognosis Based on Data from TELEREH-HF Randomized Clinical Trial (2022) (0)
The effects of statins on the function and differentiation of blood cells (2022) (0)
Blood pressure and kidney update 2016/2017 (2018) (0)
Norwegia - ziemia obiecana? (2004) (0)
Abstract 18190: Impact of Age and Gender on Clinical Outcomes in the Edoxaban versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Randomized Trial (2017) (0)
Could Lowering Phytosterol Absorption as Part of Lipid-Lowering Therapy Have a Beneficial Effect on Residual Risk? (2023) (0)
Higher Plasma Levels of Valerate Produced by Gut Microbiota May Have a Beneficial Impact on Renal Function. (2023) (0)
Factors of Persistent Limited Exercise Tolerance in Patients after COVID-19 with Normal Left Ventricular Ejection Fraction (2022) (0)
Lipoprotein(a) and the risk of atrial fibrillation – is there a link (2017) (0)
Dysfunctional HDL: the journey from savior (2014) (0)
P3396Identification of patients at extremely-high cardiovascular risk within a very-high risk population from the TERCET Registry (2019) (0)
New face of Archives of Medical Science (2006) (0)
The effects of oral trehalose in patients with diabetes: a pilot randomized controlled trial (2023) (0)
Cardiovascular primary prevention risk factors in a nationwide survey, ABC (atrial fibrillation, high blood pressure and high cholesterol) risk factors in the LIPIDOGRAM2015 study (2021) (0)
The management of Heart Failure – state after publication of European Society of Cardiology Guidelines (2005) and results of CIBIS III Trial (1999) (0)
Usefulness of atherogenic dyslipidemia index to assess the cardiovascular risk of primary care patients - Results from lipidogram 2004 and lipidogram 2006 studies. (2017) (0)
Effect of myocardial revascularization on left ventricular systolic function in patients with heart failure (2006) (0)
ORIGINAL PAPER The lipid disorders therapy in overweight patients (2005) (0)
Koszyk made in USA (2007) (0)
EFFECT OF EVOLOCUMAB ON LOW-DENSITY LIPOPROTEIN PARTICLES (2016) (0)
Factors and Prognostic Significance of Impaired Exercise Tolerance in Women over 40 with Arterial Hypertension (2021) (0)
Which features of metabolic syndrome have the highest correlation with coronary artery disease confirmed in angiography in patients with acute coronary syndrome treated with primary percutaneous transluminal coronary angioplasty (2006) (0)
PCV5 The Effeects of Statins on Blood Presure in Normotensive or Hypertensive Subjects-a Meta-Analysis of 18 Randomized Controlled Trials Involving 5628 Participants (2012) (0)
Nephroprotectiveandclinical potentialofstatinsin dialyzedpatients (2009) (0)
SU87PCSK9 GENETIC VARIANTS, LIFE-LONG LOWERING OF LOW-DENSITY LIPOPROTEIN CHOLESTEROL, AND COGNITIVE ABILITIES (2019) (0)
Factors that Influence Bempedoic Acid-Mediated Reductions in High-sensitivity C reactive Protein: Analysis of Pooled Patient-level Data from Phase 3 Clinical Trials† (2020) (0)
Abstract 16528: Impact of Alirocumab on Apolipoprotein B, Non-High-Density Lipoprotein Cholesterol, and Triglycerides in Patients With and Without Moderate Chronic Kidney Disease (2016) (0)
P5364Safety profile of bempedoic acid: pooled analysis of 4 phase 3 clinical trials (2019) (0)
“Apple does not fall far from the tree” – subclinical atherosclerosis in children with familial hypercholesterolemia (2020) (0)
Novel strategies of hypertension management in chronic kidney disease (2020) (0)
The influence of cardiological rehabilitation on arterial pressure in patients with primary hypertension (1999) (0)
The Effect of Intravenous Trehalose Administration in a Patient with Multiple Sulfatase Deficiency: A Case Study (2023) (0)
Editorial: atrial fibrillation after coronary surgery: the need for an effective pharmacological prophylaxis. (2014) (0)
556 Estimation of antioxidative effect of carvedilol in patients with ischaemic heart failure (2006) (0)
Acute suppurative left parotitis after myocardial revascularization burgey: a case report (2010) (0)
INCREASED HEART RATE AS A PREDICTOR OF CARDIOVASCULAR COMPLICATIONS IN SUBJECTS WITH METABOLIC SYNDROME AND HIGH CARDIOVASCULAR RISK (2008) (0)
Author Correction: Impact of ezetimibe on plasma lipoprotein(a) concentrations as monotherapy or in combination with statins: a systematic review and meta-analysis of randomized controlled trials (2020) (0)
Trehalose-induced alterations in serum expression levels of microRNAs associated with vascular inflammation in patients with coronary artery disease - the pilot results from the randomized controlled trial. (2022) (0)
In Reply: ACEI and ARB - Each Unique RAAS Inhibitors: The Importance of Impact on Inflammation. (2023) (0)
Bempedoic Acid Efficacy and Safety in High CVD Risk Patients Treated With or Without Ezetimibe: Pooled Analysis of 4 Phase 3 Clinical Trials† (2020) (0)
"Open Access" czy "Pay for Preview" (2007) (0)
Hipotonia ortostatyczna u osób w wieku podeszłym - rozpoznawanie i leczenie Orthostatic hypotension in the elderly - diagnosis and treatment (2008) (0)
Cognitive impairment and an episode of major depression as independent factors of delirium after cardiac surgery. Prospective observational study (2011) (0)
Keep your fingers crossed – AMS is bent on the scientific medical word conquest (2006) (0)
P1523Association of ideal cardiovascular health metrics with serum uric acid and inflammation: a population-base survey (2018) (0)
P3836The prognostic accuracy of bleeding risk prediction scores in patients with atrial fibrillation: a systematic review and meta-analysis (2018) (0)
Beta-blockers in patients following AMI and in the course of supraventricular and ventricular arrhythmias. (1999) (0)
81Efficacy and safety of alternate-day versus daily dosing of statins: a systematic review and meta-analysis (2017) (0)
Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a) (2023) (0)
LCZ696 (sacubitril/valsartan) for patients with heart failure (2020) (0)
Subject Index Vol. 116, 2010 (2010) (0)
Neonatal Shunt Operations (2008) (0)
Highlights from 2022 in EHJ Open (2022) (0)
Egg Intake: Getting the Balance Right! (2020) (0)
Use of sotalol in the prevention of atrial fibrillation in patients after coronary artery bypass grafting (2005) (0)
Influence of obstructive sleep apnea on cardiovascular diseases – case report (2007) (0)
Abstract P179: Systolic Blood Pressure and Risk for Cardiovascular Disease Among Adults 60 Years and Older without Diabetes or Chronic Kidney Disease (2016) (0)
EDOXABAN THERAPY INCREASES TREATMENT SATISFACTION AND REDUCES UTILIZATION OF HEALTH CARE RESOURCES: AN ANALYSIS FROM THE EDOXABAN VERSUS WARFARIN IN SUBJECTS UNDERGOING CARDIOVERSION OF ATRIAL FIBRILLATION (ENSURE-AF) STUDY (2017) (0)
The assessment of selected markers of cardiac dysfunction in the analysis of cardiovascular risk in dialysis patients. (2017) (0)
3100Effects of morning versus evening statin therapy on lipid profile: a systematic review and meta-analysis (2017) (0)
Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy (2022) (0)
Investigating DYS functional-HDL in selected groups of patients at high risk of cardiovascular events (DYS-HDL study) - Protocol and organization (2014) (0)
ESTIMATION OF CARDIOVASCULAR COMPLICATIONS IN SUBJECTS WITH METABOLIC SYNDROME AND HIGH CARDIOVASCULAR RISK (2008) (0)
387 Mechanical aortic valvae replacement in patients with stenosis or aortic valve regurgitation. The influence on improvement of haemodynamic parameters of heart (2004) (0)
Where is the Archives of Medical Science journal heading (2006) (0)
Abstract 13130: Efficacy and Safety of Bempedoic Acid by Sex: Pooled Analyses From Phase 3 Trials (2020) (0)
Effects of statins on the incidence and outcomes of acute kidney injury in critically ill patients: a systematic review and meta-analysis (2023) (0)
P873Plasma PCSK9 levels and atherosclerosis burden in the coronary arteries of patients undergoing coronary angiography (2019) (0)
Atrial Fibrillation After Isolated Coronary Surgery Affects Late Survival Arrhythmia/Electrophysiology (2008) (0)
P5417Consumption of dairy product and its association with total and cause specific mortality - A population-based cohort study and meta-analysis (2018) (0)
Homozygous familial hypercholesterolaemia: Shedding new light on a rare but deadly condition. (2022) (0)
Prognostic Impact of Hybrid Comprehensive Telerehabilitation Regarding Diastolic Dysfunction in Patients with Heart Failure with Reduced Ejection Fraction—Subanalysis of the TELEREH-HF Randomized Clinical Trial (2022) (0)
Statin Intolerance—We Know Everything, We Know Nothing (2022) (0)
Does trastuzumab-related cardiotoxicity influence long-term outcome in patients with HER-2 positive breast cancer? A prospective study (2021) (0)
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network. (2023) (0)
Age-Related Differences in the Role of Risk Factors for Ischemic Stroke (2023) (0)
Implications of the 2021 ESC cardiovascular risk classification among 283,000 European immigrants living in a low-risk region: a population-based analysis in Catalonia (2021) (0)
Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 (2020) (0)
P6229Potato consumption is associated with total and cause-specific mortality: a population-based cohort study and pooling of prospective studies with 73,717 participants (2019) (0)
1446A greater healthy behaviors score is associated with a lower risk of all-cause and cause specific mortality: insight from two prospective multi-ethnic surveys (2019) (0)
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network. (2023) (0)
P1452 A rare case of embolic blindness in an adult patient with univentricular heart after fontan operation (2020) (0)
Reply to Preoperative n-3 Polyunsatured Fatty Acids Do Not Reduce Postoperative Atrial Fibrillation in Cardiac Surgery, by Takagi I. and Umemoto T (2011) (0)
Abstract P051: Healthy Lifestyle Factors are Uncommon and Associated with Reduced Risk of Cardiovascular Disease and Mortality in Candidates for Primary Prevention with Statin Therapy (2015) (0)
Obesity and Body Mass Components Influence Exercise Tolerance and the Course of Hypertension in Perimenopausal Women (2022) (0)
The effect of elevated triglycerides and purified eicosapentaenoic acid ethyl ester (EPA) for cardiovascular risk reduction in the UK Biobank population (2020) (0)
Abstract 14506: Effect of Evolocumab on Lipoprotein Profiles in Patients With and Without Diabetes (2016) (0)
Invited review Arterial hypertension in patients with coronary artery disease treated with coronary artery bypass surgery (2009) (0)
The potential role of mitochondrial ATP synthase inhibitory factor 1 (IF1) in coronary heart disease: a literature review (2017) (0)
247 Postoperative mortality and preoperative atrial fibrillation, is there a significant link? (2006) (0)
Predictors of proarrhythmic effect in heart failure patients after 9-week hybrid comprehensive telerehabilitation and their influence on cardiovascular mortality in long-term follow-up: Subanalysis of the TELEREH-HF randomized clinical trial. (2022) (0)
P820The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in Poland: results of the TERCET Registry (2019) (0)
Edinburgh Research Explorer The role of survival motor neuron protein (SMN) in protein homeostasis (2018) (0)
Adiposity mediates the association between bilirubin, glucose/insulin homeostasis and inflammation (2020) (0)
A higher ratio of re ﬁ ned grain to whole grain is associated with a greater likelihood of chronic kidney disease: a population-based study (2019) (0)
The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction (2017) (0)
On Distance-Based Algorithms in Medical Applications (2009) (0)
P2626Higher dietary acids load is associated with higher likelihood of peripheral arterial disease among American adults (2018) (0)
P6348The potential role of inflammation in cryptogenic stroke (2018) (0)
Clinical features of familial hypercholesterolaemia in children and adults – the PMMHRI Registry (2021) (0)
Effects of Implementing Personalized Health Education in Ambulatory Care on Cardiovascular Risk Factors, Compliance and Satisfaction with Treatment (2022) (0)
902 Risk factors of supraventricular arrhythmias before and after surgical closure of atrial septal defect (ASD t.2) in adults (2005) (0)
Systolic blood pressure levels and coronary heart disease, stroke, heart failure, and falls among adults 65 years and older taking antihypertensive medication (2015) (0)
Effects of Trehalose Administration in Patients with Mucopolysaccharidosis Type III. (2023) (0)
[L-arginine in reperfusion solution as a heart protecting factor]. (2004) (0)
HEAD-TO-HEAD COMPARISON OF STATINS VERSUS FIBRATES IN REDUCING PLASMA FIBRINOGEN CONCENTRATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS (2016) (0)
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the international lipid expert panel (ILEP). (2023) (0)
Refractory hypertension due to the presence of additional renal arteries (2012) (0)
HYDROPHILIC VERSUS LIPOPHILIC STATINS IN CORONARY ARTERY DISEASE UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2017) (0)
Protective effects of anionic nanoliposomes on hyperlipidemia and atherosclerosis progression in a rabbit model (2020) (0)
Correction to: Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis (2020) (0)
Short Communication Preoperative predictors of delirium after cardiac surgery: a preliminary study (2006) (0)
EFFECT OF EVOLOCUMAB ON REMNANT LIPOPROTEIN PARTICLES (2016) (0)
Kardiochirurgia dorosłych Surgical ablation using the Estech Cobra system in patients with permanent atrial fibrillation treated due to mitral valve disease. A preliminary study (2008) (0)
Abstract 14248: Efficacy and Safety of Bempedoic Acid in Patients Who Cannot Tolerate Statins: Pooled Analysis of 4 Phase 3 Clinical Trials (2020) (0)
Patient after correction Taussig‐Bing anomaly with severe neo‐aortic regurgitation after sudden cardiac arrest (2021) (0)
Review paper Current position of nebivolol in the treatment of cardiovascular diseases (2009) (0)
The role of intraoperative transesophageal echocardiography in tricuspid valve annuloplasty - 15 years follow-up (1988-2003) (2005) (0)
Menopause and women’s cardiovascular health: is it really an obvious relationship? (2022) (0)
Associations between serum triglycerides and abdominal aortic calcification in a cross-sectional study from the United States of America (2021) (0)
Cardiovascular Preventive Management in Pre-Elderly and Elderly Patients with Type 2 Diabetes Mellitus in Primary Care (2016) (0)
Abstract 20566: Lower Discharge Systolic Blood Pressure (SBP) and Poor Outcomes among Hospitalized Patients With Heart Failure and Preserved Ejection Fraction (HFpEF) and Stable Admission-to-Discharge SBP (2016) (0)
Does plasma fibrinogen concentration in patients with metabolic syndrome correlate with progression of coronary artery disease in acute coronary syndrome (2006) (0)
952Telomere length is associated with serum antioxidant levels in US adults (2017) (0)
Carotid Sinus Syndrome (2019) (0)
P5505The efficacy and safety of the use of drug-eluting stents vs bare metal stents stratifying by antithrombotic therapy in atrial fibrillation patients undergoing coronary stenting: a systematic review (2018) (0)
Non-alcoholic Fatty Liver Disease, Metabolic syndrome, and Type 2 diabetes mellitus: Where do we stand today? (2022) (0)
Abstract 12268: Efficacy of Bempedoic Acid: A Pooled Analysis of 4 Pivotal Phase 3 Clinical Trials (2019) (0)
Dyslipidemia and Diabetes (2022) (0)
EARLY (1-10 DAYS) READMISSION IS ASSOCIATED WITH A SIGNIFICANTLY LOWER 2-12 MONTHS POST-DISCHARGE ALL-CAUSE MORTALITY AMONG OLDER MEDICARE BENEFICIARIES HOSPITALIZED FOR HEART FAILURE WITH 30-DAY ALL-CAUSE READMISSIONS (2016) (0)
Abstract 17400: Evaluation of Estimated and Directly Measured Remnant Lipoprotein Cholesterol: The Very Large Database of Lipids (2016) (0)
Toxic epidermal necrolysis (Lyell's syndrome): case report and review of the literature (2008) (0)
Adiposity mediates the association between whole grain consumption, glucose homeostasis and insulin resistance: findings from the US NHANES (2018) (0)
Modulation and personalization of therapy after acute coronary syndromes: the road to precision. (2023) (0)
Parenteral systems for statin delivery: a review (2019) (0)
71 Effect of myocardial revascularization on left ventricular systolic function in patients with heart failure (2006) (0)
Incomplete revascularization in patients with intensive arteriosclerosis of coronary vessels (1999) (0)
Dietary salt intake and atherosclerosis: an area not fully explored (2023) (0)
Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke: impact on arrhythmia in 3 months follow-up (2021) (0)
P5326Effect of evolocumab on lipoprotein(a) levels: results across 15 studies (2019) (0)
Influence of HbA 1c level on lipid abnormalities in patients with coronary artery disease, diagnosed with coronary angiography (2006) (0)
The interplay between peripheral organs and the heart in heart failure (2019) (0)
Efficacy and Safety of Bempedoic Acid in Elderly Patients: Pooled Analyses from Phase 3 Trials (2020) (0)
207 Intraoperative ablation in patients with atrial fibrillation subjected to mitral valve replacement. Two years follow-up (2005) (0)
Myocardial infarction – the increasing problem in young people (2006) (0)
Heart failure patients' adherence to hybrid comprehensive telerehabilitation and its impact on prognosis based on data from TELEREH-HF randomized clinical trial (2020) (0)
FROM EDITOR-IN-CHIEF Dear Readers (2005) (0)
Review for "Risk of Cardiovascular Events in Patients with Hypertriglyceridemia: A Review of Real‐World Evidence" (2019) (0)
Lipid profile and left ventricular geometry pattern in obese children (2020) (0)
Risk of death of patients from general surgery units based on patient classification into international classification of disease ( ICD-10 ) categories (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Maciej Banach?

Maciej Banach is affiliated with the following schools:

Maciej Banach's Academic­Influence.com Rankings

Why Is Maciej Banach Influential?

Maciej Banach's Published Works

Published Works

What Schools Are Affiliated With Maciej Banach?

Image Attributions

Maciej Banach's AcademicInfluence.com Rankings